Hassan Abolhassani
1. COURSES AND DEGREES:
2000-2003: Mathematic Diploma, Mofid High School, Tehran, Iran.
2003-2004: Biology & Experimental Science Diploma, Sama High School, Tehran, Iran.
2008-2012: Master of Public Health (MPH), School of Health, Tehran University of Medical Sciences, Tehran, Iran.
2012-2013: Master of Philosophy (MPhil), Research Accessory of Tehran University of Medical Sciences, Tehran, Iran.
2. DOCTORAL DEGREES:
2004-2012: Medical Doctor (MD), School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
2014-2018: Philosophy of Doctoral (Ph.D.) on Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
3. POSTDOCTORAL FELLOWSHIP:
2018-2020: Postdoctoral Fellowship in Clinical Immunology, Karolinska Institutet, Stockholm, Sweden.
4. MERIT IN ESSENTIAL SCIENCE INDICATOR:
Honored as top 1% of highly cited scientific researchers in the field of Immunology, Essential Science Indicators (ESI, https://clarivate.com/).
Honored as top 2% widely cited scientists based on Stanford University ranking (Scopus/Elsevier database, since 1788 until now)
5. AFFILIATIONS:
2004 - 2010: Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
2010 - now: Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
2014- 2021: Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
2021- 2023: Division of Clinical Immunology, Department Biosciences and Nutrition, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
2023- now: Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
6. CURRENT POSITION:
Assistant Professor of Clinical Immunology, Karolinska Institutet at Karolinska University, Stockholm, Sweden
Leadership member of the steering committee at Junior Faculty, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
7. SELECTED ACADEMIC DISTINCTIONS AND OTHER MERITS:
7.1 Bibliometric parameters
Articles in the peer-reviewed journals indexed in ISI and/or Pubmed: 402
H-index: 88, i10-index: 312
Total number of citations: 61788
Sum of the latest known journal impact factor: 5411.5
Updated full list of publications (articles, books, book chapters, oral presentations): https://staff.ki.se/people/hasabo
7.2 Merit in Karolinska Institutet (KI) and Stockholms läns landsting (SLL):
Six stars scientist: First decentile of both Karolinska Institutet (KI) and Stockholms läns landsting (SLL) regarding “number of citations”, “average journal impact for top publications”, “aggregated journal impact factors”, “number of publications”, "citations average for top publications" and regarding “world’s most highly cited publications (count top 5%)” based on bibliometrics.ki.se analysis (2014-2021)
7.3 Other academic merits
2010- Grant from the International Congress of Immunology, Kobe, Japan.
2011- Prominent Researcher Award, Tehran University of Medical Sciences, Tehran, Iran.
2012- Grant from European Society for Immunodeficiencies, Florence, Italy.
2013- Distinctive Elite Medical Doctoral student (MD) of Iran, Tehran, Iran.
2013- Paramount Young Scientists of the Country in Medical Sciences, Tehran, Iran.
2014- The 1st Rank of the Best Researcher and Best Comprehensive Student in the First Student Avicenna Festival, Tehran, Iran.
2014- Grant from Primary Immunodeficiency Organization (PIO), 2014 års forskningsstöd, Stockholm, Sweden.
2015- Distinctive Elite Ph.D. Doctoral Student of Iran, Tehran, Iran.
2018- Top 10 Ph.D. thesis of Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
2021- Anna-Greta Crafoords prize, Royal Swedish Academy of Sciences.
2021- USERN LAUREATES 2021 in Medical Sciences
2022- Prof. Isil Berat Barlan Award, In Primary Immunodeficiency Diseases., Turkish Society of Immunology.
2018-now- Honored as 1% highly cited scientific researchers in the field of Immunology, Essential Science Indicators (ESI, https://clarivate.com).
2020-now-World's Top 2% widely cited scientists based on Stanford University ranking and Scopus/Elsevier database, selecting 200,000 researchers from more than 10 million scientists (since 1788 until now) with 22 scientific fields and 176 subfields taken into account.
2020- now- Top two immunologists of Iran, Essential Science Indicators (ESI, https://clarivate.com).
2020- now- Ranked among the top World Experts in the following medical topics based on Expertscape (https://expertscape.com/): Primary Immunodeficiency Diseases, Common Variable Immunodeficiency, Dysgammaglobulinemia, Agammaglobulinemia, Hyper-IgM Immunodeficiency, IgA Deficiency, Severe Combined Immunodeficiency, DNA Repair-Deficiency, Immunologic Syndromes, Lymphoproliferative Disorders, Intravenous Immunoglobulins, Inborn Genetic Diseases, Ataxia Telangiectasia.
2025- now- Top second immunologists of Sweden, Essential Science Indicators (ESI, https://clarivate.com).
8. RESEARCH GRANTS OBTAINED IN OPEN COMPETITION As the main applicant:
Jeffrey Modell Diagnostic and Research Center (2020), KI Research Foundation Grants (2020), Åke Wibergs Foundation (2019), Jonas Söderquist scholarship (2018), Marcus Borgströms Foundation (2018), Ruth and Richard Julin Foundation (2017-2018), Alex and Eva Wallström Foundation (2017), ìShizu Matsumuraîs Donation (2017).
9. SCIENTIFIC COLLABORATIONS:
European Society for Immunodeficiencies, PID J project steering committee Jeffrey Modell Foundation's, Clinical Immunology Society, Henry Kunkel Society, Taskforce- World Health Organization, Coordination of Swedish cohort of patients with primary immunodeficiency, Collaboration with government agencies regarding health policy-making for immunodeficiency and measuring the burden of the disease.
10. EVALUATION OF OTHERS’ WORK:
Serving as editorial board and reviewer for international evaluations: Please see the profile in Publons: https://publons.com/a/1446038/
11. PREVIOUS SUPERVISIONS AND TEACHING:
Students supervised up to the defense of the candidate’s, with the applicant serving as co-supervisor: 3 master students, 3 MD students, 2 PhD students, 4 pediatric specialists, 3 clinical immunologist subspecialists.
12. ENGLISH PUBLICATIONS: # shared the first author. * Corresponding author
1- Abolhassani H et al. Re-evaluation of the contribution of TNFRSF13B variants to antibody deficiency. Journal of Human Immunity. 2025. doi.org/10.70962/jhi.20250016.
2- Chavoshzadeh Z, Fallah S, Zeinali V, Sharafian S, Delavari S, Mesdaghi M, Djidjik R, Belaid B, Ikinciogullari A, Haskologlu S, Dogu F, Genel F, Gulez N, Baris S, Ozen A, Karakoc-Aydiner E, Kiykim A, Meric Z, Kutukculer N, Aygun A, Aksu G, Karaca NE, Geyik M, Keles S, Reisli I, Nail Guner S, Boukari R, Hakem S, Belbouab R, Barbouche M-R, Ben-Mustapha I, Mekki N, Ben-Ali M, Sobh A, Elnagdy M, Djenouhat K, Tahiat A, Shendi HM, Alkuwaiti A, Nasrullayeva G, Alfars T, Alsukaiti N, Massaad M, Mehawej C, Megarbane A, Irani C, Elghazali G, Al-Tamemi S, Khalifa N, Alzyoud R, Gultekin SSK, Kose H, Khodaverdy H, Shamsian BS, Eslami N, Momen T, Sherkat R, Aleyasin S, Esmaeilzadeh H, Ahanchian H, Salami F, Fekrvand S, Dupre L, Ochs HD, Rezaei N, Al-Herz W, Abolhassani H*. Clinical and Molecular Findings in Actin-related Inborn Errors of Immunity: The Middle East and North Africa Registry. Frontiers in Genetics. 2025. doi.org/10.3389/fgene.2025.1584681
3- Yorgun Altunbas M, Kogler H, Abolhassani H, Akkus E, Basturk A, Akkelle E, Sayar E, Polat E, Kara A, Can S, Frohne A, Segarra-Roca A, Jimenez-Heredia R, Babayeva R, Sefer AP, Kiykim A, Bilgic Eltan S, Karakoc-Aydiner E, Ozen A, Beser OF, Boztug K, Rezaei N, Baris S. Clinical and Immunological Prognostic Factors With Novel Variants in a Large Cohort of Diacylglycerol Acyltransferase 1 Deficiency. J Allergy Clin Immunol Pract. 2025. Epub (PMID: 40154740).
4- Moeini Shad T, Taghizadeh N, Delavari S, Aghamohamadi N, Zarezadeh Mehrabadi A, Salami F, Mohammadi S, Salehi H, Fekrvand S, Tavakol M, Fathi N, Chavoshzadeh Z, Mesdaghi M, Ghadrdan M, Shafiei A, Rezaei N, Yazdani R*, Abolhassani H*. Comparison of LTT and CFSE proliferation tests in patients with inborn errors of adaptive immunity. Endocr Metab Immune Disord Drug Targets. 2025. Epub (PMID: 40183264).
5- Chin AT, Ochs HD, Kobayashi R, Abolhassani H, Alachkar H, Barmettler S, Baxendale H, Boiling K, Cantanzaro J, Chua I, Coulter T, Cunningham-Rundles C, Elcombe SE, Fischer A, Grimbacher B, Gupta S, Herriot R, Herwadkar A, Imai K, Inoue S, Kirkpatrick C, Knutsen AP, Kumararatne D, Lea E, Lin MW, Litzman J, Mahlaoui N, Moriya K, Nonoyama S, Patel S, Perez E, Quinti I, Hostoffer RW, Rothenfusser S, Sargur R, Shields A, Sogkas G, Suan D, Tan T, Thomas M, Warnatz K, Younger EM, Kuo CY. Clinical and Molecular Characteristics of X-linked Agammaglobulinemia Patients 55 Years or Older. J Allergy Clin Immunol Pract. 2025. Epub (PMID: 40571245).
6- Carbone M, Minaai M, Kittaneh M, Krausz T, Miettinen MM, Hammarström QP, Hammarström L, Abolhassani H, Pagano I, Xu R, Novelli F, Gaudino G, Pastorino S, Sarin KY, Ripley RT, Pass HI, Schrump DS, Yang H. Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 Mutations. J Thorac Oncol. 2025. Epub (PMID: 40582407).
7- Haeuser E, Byrne S, Nguyen J, Raggi C, McLaughlin SA, Bisignano C, Harris AA, Smith AE, Lindstedt PA, Smith G, Herold SJ, Nesbit OD, Noyes T, Shalev N, Olana LT, Aalipour MA, Aalruz H, Abbasifard M, Abbaspour F, Abbastabar H, AbdElHafeez S, Abdallah EM, Abdel-Hameed R, Abdelkader A, Abd-Elsalam S, Abdisa WM, Abdoun M, Abdous A, Abdulah DM, Abdullahi A, Abdullahi A, Abdul-Rahman T, Abdykerimova K, Abedi A, Abejew AA, AbeldañoZuñiga RA, Abidi SH, Abiodun O, AboKasem R, Aboagye RG, Abolhassani H, et al. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025 Jul 19;406(10500):235-260.
8- Knox AVC, Cominsky LY, Sun D, Cruz Cabrera E, Nolan BE, Ofray E, Benetti E, Visconti C, Barzaghi F, Rosenzweig SD, Lawrence MG, Sullivan KE, Yoon S, Rachimi S, Padem N, Conboy E, Stojanovic M, Petrovic G, Pasic S, Church JA, Ferdman RM, Candotti F, Arlabosse T, Theodoropoulou K, Dutmer CM, Maródi L, Szücs G, Broides A, Nahum A, Levy J, Kettunen KM, Daddali R Ravi, Seppänen MRJ, Vänttinen M, Martelius T, Grönholm J, Peri M, Azzari C, Ricci S, Ojaimi S, Edwards ES, van Zelm MC, Sun J, Abolhassani H, Pan-Hammarström Q, Hakonarson H, Mayr D, Boztug K, Boisson B, Casanova JL, Le Coz C, Poon GMK, Romberg N. Romberg N. One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying them. Blood. 2025 May 29;145(22):2549-2560.
9- Lee S, Son Y, Hwang J, Kim MS, Shin JI, Kassebaum NJ, Abate SM, Abate YH, Abd ElHafeez S, Abd-Elsalam S, Abdoun M, Abdulkader RS, Abdullahi A, Abebe M, Abedi A, Abie A, Abiodun O, Aboagye RG, Abolhassani H, et al. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nat Med. 2025 Jun;31(6):1809-1829.
10- Fathi N, Abolhassani H, Salami F, Moeini Shad T, Delavari S, Yazdani R, Kalantari A, Ebrahimi SS, Beniafard N, Mahdaviani SA, Rezaei N. NF-κB pathway variants in Iranian patients with inborn errors of immunity. Expert Rev Clin Immunol. 2025 May;21(5):667-681.
11- Esposto MP, Mahlaoui N, Abolhassani H, Van Aerde K, Cesaro S, Chandra A, Ehl S, Kracker S, Suarez F, Barlogis V, Parisi A, Maccari ME, Chinello M. Case Report: Activated PI3-kinase-δ syndrome and ovarian malignancies: a case series from the European ESID-APDS registry. Front Immunol. 2025 Apr 30;16:1572194.
12- Alkwai HM, Almaghlouth IA, Mendonça LO, Elkhalifa S, Abolhassani H, Aljumaah S, Al-Mousa H, Alosaimi MF, AlSaleem A, Avcin T, Chan WK, Espada G, Frémond ML, Gül A, Hadef D, Movahedi N, Wittkowski H, Al-Mayouf SM. International Multidisciplinary Consensus on the Definition and Clinical Approach for Monogenic Inflammatory Immune Dysregulation Disorders. Pediatric Rheumatology. Pediatr Rheumatol Online J. 2025 May 14;23(1):51.
13- Oh J, Kim S, Kim MS, Abate YH, Abd ElHafeez S; Abdelkader A; Abdi P; Abdulah DM; Aboagye RG; Abolhassani H, et al. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Respir Med. 2025 May;13(5):425-446.
14- Rao G, Mack CD, Nguyen T, Wong N, Payne K, Worley L, Gray PE, Wong M, Hsu P, Stormon MO, Preece K, Suan D, O'Sullivan M, Blincoe AK, Sinclair J, Okada S, Hambleton S, Arkwright PD, Boztug K, Stepensky P, Cooper MA, Bezrodnik L, Nadeau KC, Abolhassani H, Abraham RS, Seppänen MRJ, Béziat V, Bustamante J, Forbes Satter LR, Leiding JW, Meyts I, Jouanguy E, Boisson-Dupuis S, Uzel G, Puel A, Casanova JL, Tangye SG, Ma CS. Inborn errors of immunity reveal molecular requirements for generation and maintenance of human CD4+ IL-9-expressing cells. J Allergy Clin Immunol. 2025 Apr;155(4):1161-1178.
15- Anza-Ramirez C, Miranda JJ, Armocida B, César Correia J, Van Spall HG, Beran D, Aali A, Abate KH, Abate SM, Abbafati C, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdel-Azeem AM, Abdelmasseh M, Abd-Elsalam S, Abdelwahab A, Abdoli G, Abdollahi M, Abdoun M, Abdulah DM, Abdullah AY, Abdurehman AM, Abebe G, Abedi A, Abedi B, Abidi H, Aboagye RG, Abolhassani H, et al. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nat Commun. 2025 May 7;16(1):4235.
16- Ranjbarnejad T, Abolhassani H, Sherkat R, Salehi M, Ranjbarnejad F, Vatandoost N, Sharifi M. Exploring Monogenic, Polygenic, and Epigenetic Models of Common Variable Immunodeficiency. Hum Mutat. 2025 Apr 15;2025:1725906.
17- Fekrvand S, Saleki K, Abolhassani H, Almasi-Hashiani A, Hakimelahi A, Zargarzadeh N, Yekaninejad MS, Rezaei N. COVID-19 infection in inborn errors of immunity and their phenocopies: a systematic review and meta-analysis. Infect Dis. 2025 Apr 3:1-35.
18- Ding S, Lu N, Abolhassani H*. Assessing the Influence of Selected Permeabilization Methods on Lymphocyte Single-Cell Multi-Omics. Antibodies. 2025 Feb 10;14(1):15.
19- Salami F, Shad TM, Fathi N, Mojtahedi H, Esmaeili M, Shahkarami S, Afrakoti LGMP, Amirifar P, Delavari S, Nosrati H, Razavi A, Ranjouri MR, Yousefpour M, Esfahani ZH, Azizi G, Ashrafi M, Rezaei N, Yazdani R, Abolhassani H*. ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. J Clin Immunol. 2025 Jan 24;45(1):67.
20- Steel N, Bauer-Staeb CMM, Ford JA, Abbafati C, Abdalla MA, Abdelkader A, Abdi P, Abeldaño Zuñiga RA, Abiodun OO, Abolhassani H, et al. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health. 2025 Mar;10(3):e172-e188.
21- Delavari S, Yazdani R, Abolhassani H, Salami F, Ashournia P, Askarisarvestani A, Bahrami S, Behfar M, Bemanian MH, Cheraghi T, Darabi K, Darougar S, Ebrahimi S, Eskandarzadeh S, Eslamian G, Eslami N, Fallah S, Fallahpour M, Fekrvand S, Haghbin A, Hassanpoor Z, Hatefi Minaei H, Mesdaghi M, Mahdavi T, Marjani M, Mirazizi S, Modaresi M, Movahedi M, Nabavi M, Ranjbar M, Razaghian A, Saberi M, Sadeghi-Shabestari M, Sahragard M, Saleki K, Seraj S, Seyedsalehi S, Shafiei A, Sherkat R, Shiari R, Shokri S, Tavakoli S, Vosughimotlagh A, Rezaei N. National Consensus Guideline on Diagnosis and Management of Chronic Granulomatous Disease. Immunol Genet J. 2025.8 (3):1.
22- Arndt MB, Abate YH, Abbasi-Kangevari M, Abd ElHafeez S, Abdelmasseh M, Abd-Elsalam S, Abdulah DM, Abdulkader RS, Abidi H, Abiodun O, Aboagye RG, Abolhassani H, et al. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2025 Dec 21;404(10471):2543-2583.
23- Ranjbarnejad T, Gholaminejad A, Abolhassani H, Sherkat R, Salehi M, Sharifi M. Decreased Expression of hsa-miR-142-3p and hsa-miR-155-5p in Common Variable Immunodeficiency and Involvement of Their Target Genes and Biological Pathways. Allergol Immunopathol. 2025 Jan 1;53(1):153-169.
24- Sirota SB, Doxey MC, Dominguez RMV, Bender RG, Vongpradith A, Albertson SB, Novotney A, Burkart K, Carter A, Abdi P, Abdoun M, Abebe AM, Abegaz KH, Aboagye RG, Abolhassani H, et al. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2025 Jan;25(1):36-51.
25- Whalen J, Chandra A, Kracker S, Ehl S, Seidel MG, Gulas I, Dron L, Velummailum R, Nagamuthu C, Liu S, Tutein Nolthenius J, Maccari ME. on behalf of the European Society for Immunodefciencies (ESID)-APDS Registry Working Party (Stephen Jolles, Matteo Chinello, Guillaume Le Guenno, Vera Goda, Sara Kilic, Renate Krüger, Annette Uhlmann, Marina Cavazzana, Maria Fasshauer, Geraldine Blanchard-Rohner, Michaela Semeraro, Antoinette Perlat, Winnie Ip, Etienne Merlin, Jennifer Neubert, Alison Condliffe, Pere Soler-Palacin, Sylwia Koltan, Anders Fasth, Safa Baris, Pierre Frange, Antonio Marzollo, Ulrich Baumann, Saba Azarnoush, Zohreh Nademi, Bodo Grimbacher, Elif Karakoç Aydıner, Fabian Hauck, Johannes Trück, Anna Shcherbina, Marina Garcia-Prat, Hassan Abolhassani, et al). Comparative effcacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled study. Clin Exp Immunol. 2025 Jan 21;219(1):uxae107.
26- Zuo F, Cao Y, Sun R, Wang Q, Simonelli L, Du L, Bertoglio F, Schubert M, Guerra C, Cavalli A, Hust M, Robbiani DF, Varani L, Abolhassani H, Xie XS, Hammarström L, Marcotte H, Pan-Hammarström Q. Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants. J Virol. 2025 Jan 31;99(1):e0174024.
27- Kindle G, Alligon M, Albert M H, Buckland M, Edgar J D, Gathmann B, Ghosh S, Gkantaras A, Nieters A, Pignata C, Robinson P N, Rusch S, Schuetz C, Sharapova S, Shillitoe B, Candotti F, Cant A J, Casanova JL, Etzioni A, Fischer A, Meyts I, Notarangelo L D, Pergent M, Smith C I E, Elaziz D A, Abdelkader S L M, Abitbol A, Abolhassani H, et al. Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients. Journal of Human Immunity 1(3):e20250007.
28- Adelon J, Abolhassani H, Esenboga S, Fouyssac F, Cagdas D, Tezcan I, Kuskonmaz B, Cetinkaya D, Suarez F, Mahdaviani SA, Plassart S, Mathieu AL, Fabien N, Malcus C, Morfin-Sherpa F, Billaud G, Tusseau M, Benezech S, Walzer T, De Villartay JP, Bertrand Y, Belot A. Human DNA-dependent protein kinase catalytic subunit deficiency: a comprehensive review and update. J Allergy Clin Immunol. 2024 Nov;154(5):1300-1312.
29- Karbiener M, Kindle G, Meyts I, Seppänen MRJ, Candotti F, Kamieniak M, Ilk R, Kreil TR, Seidel MG; ESID‐COVID Consortium (Abd Elaziz D, AbdelkaderSohilla LM, Abitbol A, Abolhassani H et al). Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency. J Med Virol. 2024 Jun;96(6):e29738.
30- Lim CK, Abolhassani H, Sun J. Recent Advances in Understanding The Genetics of Immunological Disorders. Front Genet. 2024 Dec 2;15:1530187.
31- Comfort H, McHugh TA, Schumacher AE, Harris A, May EA, Paulson KR, Gardner WM, Fuller JE, Frisch ME, Taylor HJ, Leever AT, Teply C, Verghese NA, Alam T, Abate YH, Abbastabar H, AbdElHafeez S, Abdelmasseh M, Abd-Elsalam S, Abdissa D, Abdoun M, Abdulkader RS, Abebe M, Abedi A, Abidi H, Abiodun O, Aboagye RG, Abolhassani H, et al. Global, regional, and national stillbirths at 20 weeks’gestation or longer in 204 countries and territories,1990–2021: findings from the Global Burden of Disease Study 2021. Lancet. 2024 Nov 16;404(10466):1955-1988.
32- Fekrvand S, Abolhassani H, Esfahani ZH, Fard NNG, Amiri M, Salehi H, Almasi-Hashiani A, Saeedi-Boroujeni A, Fathi N, Mohtashami M, Razavi A, Heidari A, Azizi G, Khanmohammadi S, Ahangarzadeh M, Saleki K, Hassanpour G, Rezaei N, Yazdani R. Cancer trends in inborn errors of immunity: a systematic review and meta-analysis. J Clin Immunol. 2024 Oct 28;45(1):34.
33- Van der Velde L, Shabaan AN, Månsson A, Wennberg P, Allebeck P, Karlsson TG, Flodin P, Eikemo TA, Knudsen AKS, Soysa I, Skogen JC, Abolhassani H et al. Alcohol-attributed disease burden and formal alcohol policies in the Nordic countries (1990–2019): an analysis using the Global Burden of Disease Study 2019. Eur J Public Health. 2024 Dec 2:ckae195.
34- Du L, Oksenych V, Wan H, Ye X, Dong J, Ye AY, Abolhassani H, Vlachiotis S, Zhang X, de la Rosa K, Hammarström L, van der Burg M, Alt FW, Pan-Hammarström Q. Orientation regulation of class switch recombination in human B cells. J Immunol. 2024 Oct 15;213(8):1093-1104.
35- Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, Aguilar GR, Mestrovic T, Smith G, Han C, Hsu RL, Chalek J, Araki DT, Chung E, Raggi C, Hayoon AG, Weaver ND, Lindstedt PA, Smith AE, Altay U, Bhattacharjee NV, Giannakis K, Fell F, McManigal B, Ekapirat N, Mendes JA, Runghien T, Srimokla O, Abdelkader A, Abd-Elsalam S, Aboagye RG, Abolhassani H, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024 Sep 28;404(10459):1199-1226.
36- Pashangzadeh S, Delavari S, Shad TM, Salami F, Rasouli SE, Yazdani R, Mahdaviani SA, Nabavi M, Aleyasin S, Ahanchian H, Azad FJ, Chavoshzadeh Z, Nazari F, Momen T, Sherkat R, Abolnezhadian F, Esmaeilzadeh H, Fallahpour M, Arshi S, Bemanian MH, Shokri S, Ebrahimi SS, Abolmolouki M, Farid AS, Rezaei A, Esmaeili M, Kalantari A, Sadeghi-Shabestari M, Shirkani A, Behniafard N, Khalili A, Eslamian MH, Cheraghi T, Shafie A, Tavakol M, Khoshkhui M, Iranparast S, Shamshiri M, Shahri MA, Khazaei R, Asadi M, Babaha F, Aghamohammadi A, Rezaei N, Abolhassani H. Non-Infectious Complications in B-Lymphopenic Common Variable Immunodeficiency. J Investig Allergol Clin Immunol. 2024 Jul;34(4):233-245
37- Yazdanpanah N, Sedikides C, Ochs HD, Camargo CA Jr, Darmstadt GL, Cerda A, Cauda V, Peters GJ, Sellke F, Wong ND, Comini E, Jimeno AR, Glover V, Hatziargyriou N, Vincenot CE, Bordas SPA, Rao IM, Abolhassani H, Gharehpetian GB, Weiskirchen R, Gupta M, Chandel SS, Olusanya BO, Cheson B, Pomponio A, Tanzer M, Myles PS, Ma WX, Bella F, Ghavami S, Moein Moghimi S, Pratico D, Hernandez AM, Martinez-Urbistondo M, Urbistondo DM, Fereshtehnejad SM, Ali I, Kimura S, Wallace Hayes A, Cai W, Ernest CKJ, Thomas S, Rahimi K, Sorooshian A, Schreiber M, Kato K, Luong JHT, Pluchino S, Lozano AM, Seymour JF, Kosik KS, Hofmann SG, McIntyre RS, Perc M, Leemans A, Klein RS, Ogino S, Wlezien C, Perry G, Nieto JJ, Levin L, Klionsky DJ, Mobasher B, Dorigo T, Rezaei N. Global Challenges Coming After a Global Challenge: Lessons Learned from COVID-19. The COVID-19 Aftermath, Adv Exp Med Biol. 2024;1457:1-31.
38- Donkó Á, Sharapova SO, Kabat J, Ganesan S, Hauck FH, Bergerson JRE, Marois L, Abbott J, Moshous D, Williams KW, Campbell N, Martin PL, Lagresle-Peyrou C, Trojan T, Kuzmenko NB, Deordieva EA, Raykina EV, Abers MS, Abolhassani H, Barlogis V, Milla C, Hall G, Mousallem T, Church J, Kapoor N, Cros G, Chapdelaine H, Franco-Jarava C, Lopez-Lerma I, Miano M, Leiding JW, Klein C, Stasia MJ, Fischer A, Hsiao KC, Martelius T, Sepännen MRJ, Barmettler S, Walter J, Masmas TN, Mukhina AA, Falcone EL, Kracker S, Shcherbina A, Holland SM, Leto TL, Hsu AP. Clinical and functional spectrum of RAC2-related immunodeficiency. Blood. 2024 Apr 11;143(15):1476-1487.
39- Jin Y, Guo C, Abbasian M, Abbasifard M, Abbott JH, Abdullahi A, Abedi A, Abidi H, Abolhassani H, et al. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050. Med. 2024 Aug 9;5(8):943-962.e6.
40- Fekrvand S, Abolhassani H, Rezaei N. An overview of early genetic predictors of IgA deficiency. Expert Rev Mol Diagn. 2024 Aug;24(8):715-727.
41- Fathi N, Nirouei M, Salimian Rizi Z, Fekrvand S, Abolhassani H, Salami F, Haj Mohamad A, Ketabforoush E, Azizi G, Saghazadeh A, Esmaeili M, Almasi-Hashiani A, Rezaei N. Clinical, Immunological, and Genetic Features in Patients with NFKB1 and NFKB2 mutations: A Systematic Review. J Clin Immunol. 2024 Jul 11;44(7):160.
42- Novelli F, Yoshikawa Y, Vitto VAM, Modesti L, Minaai M, Pastorino S, Emi M, Kim JH, Kricek F, Bai F, Onuchic JN, Bononi A, Suarez JS, Tanji M, Favaron C, Zolondick AA, Xu R, Takanishi Y, Wang Z, Sakamoto G, Gaudino G, Grzymski J, Grosso F, Schrump DS, Pass HI, Atanesyan L, Smout J, Savola S, Sarin KY, Abolhassani H, Hammarström L, Pan-Hammarström Q, Giorgi C, Pinton P, Yang H, Carbone M. Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and Calcium signaling. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2405231121.
43- Ledesma JR, Ma J, Zhang M, Basting AVL, Chu HT, Vongpradith A, Novotney A, LeGrand KE, Xu YY, Dai X, Nicholson SI, Stafford LK, Carter A, Ross JM, Abbastabar H, Abdoun M, Abdulah DM, Aboagye RG, Abolhassani H, et al. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024 Jul;24(7):698-725.
44- Movahedi M, Movahedi M, Parvaneh N, Abolhassani H, Mahdavi M, Mosavikhorshidi MS, Alizadeh F, Shokri M, Kalantari A. Antibody Response Before and After the Booster Dose of Inactivated Corona Vaccine in Antibody Deficient Patients. Iran J Allergy Asthma Immunol. 2024 Apr 7;23(2):158-167.
45- Santos JV, Padron-Monedero A, Bikbov B, Grad DA, Plass D, Mechili EA, Gazzelloni F, Fischer F, Sulo G, Ngwa CH, Noguer-Zambrano I, Peñalvo JL, Haagsma JA, Kissimova-Skarbek K, Monasta L, Ghith N, Sarmiento-Suarez R, Hrzic R, Haneef R, O'Caoimh R, Cuschieri S, Mondello S, Kabir Z, Abbafati C, Abolhassani H, et al. The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019. BMC Public Health. 2024 May 22;24(1):1374.
46- Schumacher AE, Kyu HH, Aali A, Abbafati C, Abbas J, Abbasgholizadeh R, Abbasi MA, Abbasian M, Abd ElHafeez S, Abdelmasseh M, Abd-Elsalam S, Abdelwahab A, Abdollahi M, Abdoun M, Abdullahi A, Abdurehman AM, Abebe M, Abedi A, Abedi A, Abegaz TM, Abeldaño Zuñiga RA, Abhilash ES, Abiodun OO, Aboagye RG, Abolhassani H, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):1989-2056.
47- Mahdavi FS, Tavakol M, Aghamahdi F, Sadri H, Chavoshzadeh Z, Jamee M, Noorian S, Alaei MR, Ashkevari P, Anaya JM, Abolhassani H, Ochs HD, Azizi G. Immunological Evaluation of Pediatric Patients with Polyautoimmunity. Endocr Metab Immune Disord Drug Targets. 2024;24(7):798-807.
48- Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, Abbasi-Kangevari M, Abbastabar H, Abd ElHafeez S, Abdelmasseh M, Abd-Elsalam S, Abdelwahab A, Abdollahi M, Abdollahifar M, Abdoun M, Abdulah DM, Abdullahi A, Abebe M, Abebe SS, Abedi A, Abegaz KH, Abhilash ES, Abidi H, Abiodun O, Aboagye RG, Abolhassani H, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2100-2132.
49- Bhattacharjee NV, Schumacher AE, Aali A, Abate YH, Abbasgholizadeh R, Abbasian M, Abbasi-Kangevari M, Abbastabar H, Abd ElHafeez S, Abd-Elsalam S, Abdollahi M, Abdollahifar M, Abdoun M, Abdullahi A, Abebe M, Abebe SS, Abiodun O, Abolhassani H, et al. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2057-2099.
50- Avan A, Feigin VL, Bennett DA, Steinmetz, JD, Hachinski V, Stranges S, Owolabi MO, Aali A, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abd-Allah F, Abdollahzade S, Abidi H, Abolhassani H, et al. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Glob Health. 2024 Jun;12(6):e960-e982.
51- Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, Abd ElHafeez S, Abdelmasseh M, Abd-Elsalam S, Abdollahi A, Abdullahi A, Abegaz KH, Abeldaño Zuñiga RA, Aboagye RG, Abolhassani H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2133-2161.
52- Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasi MA, Abbasian M, Abbasifard M, Abbasi-Kangevari M, Abd ElHafeez S, Abd-Elsalam S, Abdi P, Abdollahi M, Abdoun M, Abdulah DM, Abdullahi A, Abebe M, Abedi A, Abedi A, Abegaz TM, Abeldaño Zuñiga RA, Abiodun O, Abiso TL, Aboagye RG, Abolhassani H, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2162-2203.
53- Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, Abbastabar H, Abd Al Magied AH, Abd ElHafeez S, Abdelkader A, Abdelmasseh M, Abd-Elsalam S, Abdi P, Abdollahi M, Abdoun M, Abdullahi A, Abebe M, Abiodun O, Aboagye RG, Abolhassani H, et al. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2204-2256.
54- McDonnell J, Cousins K, Younger MEM, Lane A, Abolhassani H, et al. COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. J Clin Immunol. 2024 Apr 5;44(4):86.
55- Delavari S, Rasouli SE, Fekrvand S, Chavoshzade Z, Mahdaviani SA, Shirmast P, Sharafian S, Sherkat R, Momen T, Aleyasin S, Ahanchian H, Sadeghi-Shabestari M, Esmaeilzadeh H, Barzamini S, Tarighatmonfared F, Salehi H, Esmaeili M, Marzani Z, Fathi N, Abolnezhadian F, Rad MK, Saeedi-Boroujeni A, Shirkani A, Bagheri Z, Salami F, Shad TM, Marzbali MY, Mojtahedi H, Razavi A, Tavakolinia N, Cheraghi T, Tavakol M, Shafiei A, Behniafard N, Ebrahimi SS, Sepahi N, Ghaneimoghadam A, Rezaei A, Kalantari A, Abolhassani H*, Rezaei N*. Clinical heterogeneity in families with multiple cases of inborn errors of immunity. Clin Immunol. 2024 Feb; 259:109896.
56- Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C, Cavallera V, Cousin E, Hagins H, Moberg ME, Mehlman ML, Abate YH, Abbas J, Abbasi MA, Abbasian M, Abbastabar H, Abdelmasseh M, Abdollahi M, Abdollahi M, Abdollahifar M, Abd-Rabu R, Abdulah DM, Abdullahi A, Abedi A, Abedi V, Abeldaño Zuñiga RA, Abidi H, Abiodun O, Aboagye RG, Abolhassani H, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024 Apr;23(4):344-381.
57- Sharma R, Abbastabar H, Abdulah DM, Abidi H, Abolhassani H, et al. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study. Lancet Reg Health Southeast Asia. 2024 Jan 2:21:100333.
58- Taghizadeh N, Mohammadi S, Abolhassani H, Shokri S, Nabavi M, Fallahpour M, Bemanian MH. From variant of uncertain significance to likely pathogenic in two siblings with atypical RAG2 Deficiency: a case report and review of the literature. BMC Pediatr. 2024 Feb 13;24(1):116.
59- Delavari S, Esmaeili M, Salami F, Rasouli SE, Fekrvand S, Marzbali MY, Fathi N, Abolhassani H. Pulmonary Complications of Monogenic Patients with Common Variable Immunodeficiency: COVID-19 Perspectives. Turk J Immunol 2024;12(Suppl 1):1-12.
60- Marcotte H, Cao Y, Zuo F, Simonelli L, Sammartino JC, Pedotti M, Sun R, Cassaniti I, Hagbom M, Piralla A, Yang J, Du L, Percivalle E, Bertoglio F, Schubert M, Abolhassani H, Sherina N, Guerra C, Borte S, Rezaei N, Kumagai-Braesch M, Xue Y, Su C, Yan Q, He P, Grönwall C, Klareskog L, Calzolai L, Cavalli A, Wang Q, Robbiani DF, Hust M, Shi Z, Feng L, Svensson L, Chen L, Bao L, Baldanti F, Xiao J, Qin C, Hammarström L, Yang X, Varani L, Xie XS, Pan-Hammarström Q. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages. Proc Natl Acad Sci U S A. 2024 Jan 16;121(3):e2315354120.
61- Bastard P, Gervais A, Taniguchi M, Saare L, Särekannu K, Le Voyer T, Philippot Q, Rosain J, Bizien L, Asano T, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Tandjaoui-Lambiotte Y, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Abi Haidar A, Soudee C, Arseguel V, Abolhassani H, et al. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. J Exp Med. 2024 Feb 5;221(2):e20231353.
62- Zuo F, Cao Y, Sun R, Yisimayi A, Du L, Bertoglio F, Schubert M, Guerra C, Cavalli A, Hust M, Robbiani DF, Abolhassani H, Xie XS, Hammarström L, Marcotte H, Pan-Hammarström Q. Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86. Lancet Infect Dis. 2024 Jan;24(1):e7-e9.
63- Armocida B, Monasta L, Sawyer SM, Bustreo F, Onder G, Castelpietra G, Pricci F, Minardi V, Giacomozzi C, Abbafati C, Stafford LK, Pasovic M, Hay SI, Ong KL, Perel P, Beran S, Abolhassani H, et al .The Burden of Type 1 and Type 2 Diabetes Among Adolescents and Young Adults in 24 Western European Countries, 1990–2019: Results From the Global Burden of Disease Study 2019. Int J Public Health 2024 Feb 68:1606491.
64- Black RJ, Cross M, Haile LM, Culbreth GT, Steinmetz JD, Hagins H, Kopec JA, Brooks PM, Woolf AD, Ong KL, Kopansky-Giles DR, Dreinhoefer KE, Betteridge N, Aali A, Abbasifard M, Abbasi-Kangevari M, Abdurehman AM, Abedi A, Abidi H, Aboagye RG, Abolhassani H, et al. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 Sep 25;5(10):e594-e610.
65- Zavareh FT, Mirshafiey A, Yazdani R, Keshtkar AA, Abolhassani H, Kiaee F, Parvaneh N, Shariat M, Rezaei N, Aghamohammadi A. Analysis of Lymphocyte and Clinical Profile among Non-monogenic Common Variable Immunodeficiency Patients with and without Class Switch Recombination Defect. J Investig Allergol Clin Immunol. 2023 Dec 14;33(6):474-476.
66- Maccari ME, Wolkewitz M, Schwab C, Lorenzini T, Leiding JW, Aladjdi N, Abolhassani H, et al. Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. J Allergy Clin Immunol. 2023 Oct;152(4):984-996
67- Gardner WM, Razo C, McHugh TA, Hagins H, Vilchis-Tella VM, Hennessy C, Taylor HJ, Perumal N, Fuller K, Cercy KM, Zoeckler LZ, Chen CS, Lim SS, Aali A, Abate KH, Abd-Elsalam S, Abdurehman AM, Abebe G, Abidi H, Aboagye RG, Abolhassani H, et al. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021. Lancet Haematol. 2023 Sep;10(9):e713-e734
68- Aoun M, Coelho A, Krämer A, Saxena A, Sabatier P, Beusch CM, Lönnblom E, Geng M, Do NN, Xu Z, Zhang J, He Y, Castillo LR, Abolhassani H, Xu B, Viljanen J, Rorbach J, Lahore GF, Gjertsson I, Kastbom A, Sjöwall C, Kihlberg J, Zubarev RA, Burkhardt H, Holmdahl R. Antigen presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis. J Exp Med. 2023 Nov 6;220(11):e20230101.
69- Wu D, Jin Y, Xing Y, Abate MD, Abbasian M, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abd-Allah F, Abdelmasseh M, Abdollahifar M, Abdulah DM, Abedi A, Abedi V, Abidi H, Aboagye RG, Abolhassani H, et al. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.GBD 2019 IMID Collaborators.EClinicalMedicine. 2023 Sep 9;64:102193.
70- Ong Kl, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, Dalton BE, Duprey J, Cruz JA, Hagins H, Lindstedt PA, Aali A, Abate YH, Abate MD, Abbasian M, Abbasi-Kangevari Z, Abbasi-Kangevari M, Abd ElHafeez S, Abd-Rabu R, Abdulah DM, Abdullah AY, Abedi V, Abidi H, Aboagye RG, Abolhassani H, et al. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023 Jul 15;402(10397):203-234.
71- Shin YH, Hwang J, Kwon R, Lee SW, Kim MS, Abate YH, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abdelmasseh M, Abdulah DM, Aboagye RG, Abolhassani H, et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy. 2023.78;8 2232-2254.
72- Wunrow HY, Bender RG, Vongpradith A, Sirota SB, Swetschinski LR, Novotney A, Gray AP, Ikuta KS, Sharara F, Wool EE, Aali A, Abd-Elsalam S, Abdollahi A, Abdul Aziz JM, Abidi H, Aboagye RG, Abolhassani H, et al. GBD 2019 Meningitis and Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2023; 22: 685–711.
73- Azzopardi PS, Kerr JA, Francis KL, Sawye SM, Kennedy EC, Steer AC, Graham, SM, Viner RM, Ward JL, Hennegan J, Pham MD, Habito CM, Kurji J, Cini KI, Beeso JG, Brown A, Murray CJ, Abbasi-Kangevari M, Abolhassani H, et al. GBD 2019 Child and Adolescent Communicable Disease Collaborators. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet. 2023 Jul 22;402(10398):313-335.
74- Azizi G, Hesari MF, Sharifinejad N, Fayyaz F, Chavoshzadeh Z, Mahdaviani SA, Alan MS, Jamee M, Tavakol M, Sadri H, Shahrestanaki E, Nabavi M, Ebrahimi SS, Shirkani A, Vosughi Motlagh A, Delavari S, Rasouli SE, Esmaeili M, Salami F, Yazdani R, Rezaei N, Abolhassani H*. The autoimmune manifestations in patients with genetic defects in the B cell development and differentiation stages. J Clin Immunol. 2023 May;43(4):819-834.
75- Baris S Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, Reisli I, Tahiat A, Shendi HM, Elaziz DA, Belaid B, Al Dhaheri F, Haskologlu S, Dogu F, Ben-Mustapha I, Sobh A, Galal N, Meshaal S, Elhawary R, El-Marsafy A, Alroqi FJ, Al-Saud B, Al-Ahmad M, Al Farsi T, Sukaiti NA, Al-Tamemi S, Mehawej C, Dbaibo G, ElGhazali G, Kilic SS, Genel F, Kiykim A, Musabak U, Artac H, Guner SN, Boukari R, Djidjik R, Kechout N, Cagdas D, El-Sayed ZA, Karakoc-Aydiner E, Alzyoud R, Barbouche MR, Adeli M, Wakim RH, Reda SM, Ikinciogullari A, Ozen A, Bousfiha A, Al-Mousa H, Rezaei N, Al-Herz W, Geha RS. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2023 Jan;11(1):158-180.
76- Sharifinejad N, Azizi G, Rasouli SE, Chavoshzadeh Z, Mahdaviani SA, Tavakol M, Sadri H, Nabavi M, Ebrahimi SS, Shirkani A, Vosughi Motlagh A, Momen T, Sharafian S, Mesdaghi M, Eslami N, Delavari S, Bahrami S, Yazdani R, Rezaei N, Abolhassani H. Autoimmune versus Non-autoimmune Cutaneous Features in Monogenic Patients with Inborn Errors of Immunity. Biology. 2023 Apr 24;12(5):644.
77- Sun R, Wang Y, Abolhassani H. Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies. Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):771-784.
78- Esmaeilzadeh H, Jokar-Derisi A, Hassani AH, Yazdani R, Delavari S, Abolhassani H, Mortazavi N, Askarisarvestani A. Assessment of the first presentations of Common Variable Immunodeficiency in a large cohort of patients. BMC Immunol. 2023 Jun 13;24(1):9.
79- Aryannejad A, Saeedi Moghaddam S, Mashinchi B, Tabary M, Rezaei N, Shahin S, Rezaei N, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abidi H, Abolhassani H, et al. National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019. Breast Cancer Res. 2023 Apr 26;25(1):47.
80- Hojabri M, Farsi Y, Jamee M, Abolhassani H, Khani HHK, Karimi A, Mesdaghi M, Chavoshzadeh Z, Sharafian S. JAGN1 Mutation with Distinct Clinical Features; Two Case Reports and Literature Review. BMC Pediatr. 2023 Apr 29;23(1):206.
81- Momtazmanesh S, Saeedi Moghaddam S, Ghamari S, Malakan Rad E, Rezaei N, Shobeiri P, Aali A, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abdelmasseh M, Abdoun M, Abdulah DM, Abdullah AY, Abedi A, Abolhassani H, et al. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023 May;59:101936.
82- Zuo F, Sun R, Abolhassani H, Du L, Wang Y, Vlachiotis S, Bertoglio F, Schubert M, Rezaei N, Chavoshzadeh Z, Guerra C, Cavalli A, Andréll J, Kumagai-Braesch M, Xue Y, Cao Y, Hust M, Robbiani DF, Xie XS, Hammarström L, Marcotte H, Pan-Hammarström Q.. Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1. Lancet Reg Health West Pac. 2023 Apr;33:100762.
83- Azadnajafabad S, Saeedi Moghaddam S, Mohammadi E, Rezaei N, Rashidi M, Rezaei N, AbbasiKangevari M, Abbasi-Kangevari, Z, Abbastabar H, Abidi H, Abolhassani H, et al. Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Front Oncol. 13:1132816.
84- Mohammadi F, Yadegar A, Mardani M, Ayati A, Abolhassani H, Rezaei N. Organ-based clues for diagnosis of inborn errors of immunity: a practical guide for clinicians. Immun Inflamm Dis. 2023 Apr; 11(4): e833.
85- Nguyen T, Lau A, Bier J, Cooke KC, Lenthall H, Ruiz-Diaz S, Avery DT, Brigden H, Zahra D, Sewell WA, Droney L, Okada S, Asano T, Abolhassani H, Chavoshzadeh Z, Abraham RS, Rajapakse N, Klee EW, Church JA, Williams A, Wong M, Burkhart C, Uzel G, Croucher DR, James DE, Ma CS, Brink R, Tangye SG, Deenick EK. Cellular defects underlying activated PI3Kd syndrome 2 due to PIK3R1 mutations. J Exp Med. 2023 Jun 5;220(6):e20221020.
86- Bianchini F, Crivelli V, Abernathy ME, Guerra C, Palus M, Muri J, Marcotte H, Piralla A, Pedotti M, De Gasparo R, Simonelli L, Matkovic M, Toscano C, Biggiogero M, Calvaruso V, Svoboda P, Cervantes Rincón T, Fava T, Podešvová L, Shanbhag AA, Celoria A, Sgrignani J, Stefanik M, Hönig V, Pranclova V, Michalcikova T, Prochazka J, Guerrini G, Mehn D, Ciabattini A, Abolhassani H, Jarrossay D, Uguccioni M, Medaglini D, Pan-Hammarström Q, Calzolai L, Fernandez D, Baldanti F, Franzetti-Pellanda A, Garzoni C, Sedlacek R, Ruzek D, Varani L, Cavalli A, Barnes CO, Robbiani DF. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein. Sci Immunol. 2023 Jan 26:eade0958.
87- Micah AE, Bhangdia K, Cogswell IE, Lasher D, Lidral-Porter B, Maddison ER, Nguyen, TN Patel N, Pedroza P, Solorio J, Stutzman H, Tsakalos G, Wang Y, Warriner W, Zhao Y, Zlavog BS, Abbafati C, Abbas J, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abdelmasseh M, Abdulah DM, Abedi A, Abegaz KH, Abhilash ES, Aboagye RG, Abolhassani H, et al. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. Lancet Glob Health. 2023 Mar;11(3):e385-e413.
88- Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med. 2023 Apr 5;15(1):22.
89- Delavari S, Wang Y, Moeini shad T, Pashangzadeh S, Nazari F, Salami F, Abolhassani H*. Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity. Cancers (Basel). 2023 Jan 26;15(3):764.
90- Block V, Sevdali E, Recher M, Abolhassani H, Hammarstrom L, Smulski CR, Baronio M, Plebani A, Proietti M, Speletas M, Warnatz K, Voll RE, Lougaris V, Schneider P, Eibel H. CVID-associated B cell activating factor receptor variants change receptor oligomerization, ligand binding and signaling responses. J Clin Immunol. 2023 Feb;43(2):391-405.
91- Pashangzadeh S, Yazdani R, Delavari S, Abolhassani H, Parvaneh N. Novel RAG2 Mutation in a Patient with Leaky Severe combined Immunodeficiency. Immunol Genet J. 2023. 4(4).
92- Golchehre Z, Sharafian S, Momtazmanesh N, Chavoshzadeh Z, Karimi A, Abolhassani H, et al. New Presentation of CD27 Deficiency; Coronary Ectasia and COVID-19? Iran J Allergy Asthma Immunol. 2023. Feb 20;22(1):110-118.
93- Bagheri Y, Moeini Shad T, Namazi S, Tofighi Zavareh F, Azizi G, Salami F, Sadani S, Hosseini A, Saeidi M, Pashangzadeh S, Delavari S, Mirminachi B, Rezaei N, Abolhassani H, Aghamohammadi A, Yazdani R. B cells and T cells abnormalities in patients with selective IgA deficiency. Allergy Asthma Clin Immunol. 2023 Mar 20;19(1):23.
94- Fathi N, Mojtahedi H, Nasiri M, Abolhassani H, Yousefpour Marzbali M, Esmaili M, Salami F, Biglari F, Rezaei N. How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity? Expert Rev Clin Immunol. 2022. Mar;19(3):329-339.
95- Ghadimi S, Jamee M, Abolhassani H, Parvaneh N, Rezaei N, Delavari S, Sadeghi-Shabestari M, Tabatabaei SR, Fahimzad A, Armin S, Chavoshzadeh Z, Sharafian S. Demographic, clinical, immunological, and molecular features of iranian national cohort of patients with defect in DCLRE1C gene. Allergy Asthma Clin Immunol. 2023 Feb 21;19(1):13.
96- Sepanlou SG, Rezaei Aliabadi H, AbbasiKangevari M, Abbasi-Kangevari Z, Abidi H, Abolhassani H, et al. Levels and Trends of Maternal Mortality and Morbidity by Cause in North Africa and Middle East, 1990 to 2019: An Analysis for the Global Burden of Disease Study 2019. Arch Iran Med. 2022;25(10): 666-675.
97- Rasouli SE, Tavakol M, Sadri H, Chavoshzadeh Z, Alireza Mahdaviani S, Delavari S, Jamee M, Kalantari A, Seifi Alan M, Aghamahdi F, Abolhassani H, Yazdani R, Rezaei N, Azizi G. The spectrum of inborn errors of immunity: a single tertiary center retrospective study in Alborz, Iran. Eur Ann Allergy Clin Immunol. 2023 Jan;55(1):19-28.
98- Abolhassani H, Delavari S, Landegren N, Shokri S, Bastard P, Du L, Zuo F, Hajebi R, Abolnezhadian F, Iranparast S, Modaresi M, Vosughimotlagh A, Salami F, Aranda-Guillén M, Cobat A, Marcotte H, Zhang SY, Zhang Q, Rezaei N, Casanova JL, Kämpe O, Hammarström L, Pan-Hammarström Q. Genetic and immunological evaluation of children with inborn errors of immunity and severe or critical COVID-19. J Allergy Clin Immunol. 2022 Nov;150(5):1059-1073.
99- Jamee M, Azizi G, Baris S, Karakoc-Aydiner E, Ozen A, Kiliç SŞ, Kose H, Chavoshzadeh Z, Mahdaviani SA, Momen T, Shamsian BS, Fallahi M, Sharafian S, Gülez N, Aygun A, Karaca NE, Kutukculer N, Al Sukait N, Al Farsi T, Al-Tamemi S, Khalifa N, Shereen R, El-Ghoneimy D, El-Owaidy R, Radwan N, Alzyoud R, Barbouche MR, Ben-Mustapha I, Mekki N, Rais A, Boukari R, Belbouab R, Djenouhat K, Tahiat A, Touri S, Elghazali G, Al-Hammadi S, Shendi HM, Alkuwaiti A, Belaid B, Djidjik R, Artac H, Adeli M, Sobh A, Elnagdy MH, Bahgat SA, Nasrullayeva G; MENA-I. E. I. Study Group, Chou J, Rezaei N, Al-Herz W, Geha RS, Abolhassani H*. Clinical, Immunological, Molecular and Therapeutic Findings in Monogenic Immune Dysregulation Diseases: Middle East and North Africa Registry. Clin Immunol. 2022 Sep 27;244:109131.
100- Zuo F#, Abolhassani H#, Du L#, Piralla A, Bertoglio F, de Campos-Mata L, Wan H, Schubert M, Cassaniti I, Wang Y, Sammartino JC, Sun R, Vlachiotis S, Bergami F, Kumagai-Braesch M, Andréll J, Zhang Z, Xue T, Wenzel EV, Calzolai L, Varani L, Rezaei N, Chavoshzadeh Z, Baldanti F, Hust M, Hammarström L, Marcotte H, Pan-Hammarström Q. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nat Commun.2022. May 13;13(1):2670.
101- Abolhassani H, et al. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021. Front Immunol. 2022 Dec 16;13:1032358.
102- Sharifinejad N, Azizi G, Chavoshzadeh Z, Mahdaviani SA, Seifi Alan M, Tavakol M, Sadri H, Nabavi M, Ebrahimi SS, Shirkani A, Vosughi Motlagh A, Safarirad M, Aghamahdi F, Nazari F, Delavari S, Jamee M, Fayyaz F, Samimisedeh P, Matani R, Esmaeili M, Yazdani R, Rezaei N, Abolhassani H*. Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features. Front Immunol. 2022. Front Immunol. 2022 Dec 5;13:1023127.
103- Farzadfar F, Naghavi M, Sepanlou SG, Saeedi Moghaddam S, Dangel WJ, Weaver ND, Aminorroaya A, Azadnajafabad S, Koolaji S, Mohammadi E, Rezaei N, Abbas J, Abbasi B, Abbasifard M, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdoli A, Abdollahi M, Abdollahzade A, Abolhassani H, et al. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022. Apr 23;399(10335):1625-1645.
104- Reiner RC, Welgan CA, Troeger CE, Baumann MM, Weiss DJ, Deshpande A, Blacker BF, Miller-Petrie MK, Earl L, Bhatt S, Abolhassani H, et al. The overlapping burden of the three leading causes of disability and death in sub-Saharan African children. Nat Commun. 2022 Dec 6;13(1):7457.
105- Armocida B, Monasta L, Sawyer SM, Bustreo F, Segafredo G, Castelpietra G, Ronfani L, Pasovic M, Hay SI, Abila DB, Abolhassani H, et al. Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019. Lancet Child Adolesc Health. 2022 Jun;6(6):367-383.
106- Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, Xu R, Ababneh E, Abbasi-Kangevari M, Abbastabar H, Abd-Elsalam SM, Abdoli A, Abedi A, Abidi H, Abolhassani H, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022. Mar 1;8(3):420-444.
107- Lee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M, Pescarmona R, Talouarn E, Rinchai D, Zhang P, Perret M, Liu Z, Jordan I, Elmas Bozdemir S, Bayhan GI, Beaufils C, Bizien L, Bisiaux A, Lei W, Hasan M, Chen J, Gaughan C, Asthana A, Libri V, Luna JM, Jaffré F, Hoffmann HH, Michailidis E, Moreews M, Seeleuthner Y, Bilguvar K, Mane S, Flores C, Zhang Y, Arias AA, Bailey R, Schlüter A, Milisavljevic B, Bigio B, Le Voyer T, Materna M, Gervais A, Moncada-Velez M, Pala F, Lazarov T, Levy R, Neehus AL, Rosain J, Peel J, Chan YH, Morin MP, Pino-Ramirez RM, Belkaya S, Lorenzo L, Anton J, Delafontaine S, Toubiana J, Bajolle F, Fumadó V, DeDiego ML, Fidouh N, Rozenberg F, Pérez-Tur J, Chen S, Evans T, Geissmann F, Lebon P, Weiss SR, Bonnet D, Duval X; CoV-Contact Cohort§; Covid HE (Abel L, Abolhassani H, et al.), Pan-Hammarström Q, Planas AM, Meyts I, Haerynck F, Pujol A, Sancho-Shimizu V, Dalgard C, Bustamante J, Puel A, Boisson-Dupuis S, Boisson B, Maniatis T, Zhang Q, Bastard P, Notarangelo L, Béziat V, Perez de Diego R, Rodriguez-Gallego C, Su HC, Lifton RP, Jouanguy E, Cobat A, Alsina L, Keles S, Haddad E, Abel L, Belot A, Quintana-Murci L, Rice CM, Silverman RH, Zhang SY, Casanova JL. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science. 2022 Dec 20:eabo3627.
108- Tyrovolas S, Stergachis A, Krish VS, Chang AY, Skirbekk V, Dieleman JL, Chatterji S, Abd-Allah F, Abdollahi M, Abedi A, Abolhassani H, et al. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022 Mar 10;376:e068208.
109- Alvarez EM, Force LM, Xu R, Compton K, Lu D, Henrikson HJ, Kocarnik JM, Harvey JD, Pennini A, Dean FE, Fu W, Vargas MT, Keegan TH, Ariffin H, Barr RD, Erdomaeva YA, Gunasekera DS, John-Akinola YO, Ketterl TG, Kutluk T, Malogolowkin MH, Mathur P, Radhakrishnan V, Ries LA, Rodriguez-Galindo C, Sagoyan GB, Sultan I, Abbasi B, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdelmasseh M, Abd-Elsalam S, Abdoli A, Abebe H, Abedi A, Abidi H, Abolhassani H, et al. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022 Jan;23(1):27-52.
110- Kyu HH, Vongpradith A, Sirota SB, Novotney A, Troeger CE, Doxey MC, Bender RG, Ledesma JR, Biehl MH, Albertson SB, Frostad JJ, Burkart K, Bennitt FB, Zhao JT, Gardner WM, Hagins H, Bryazka D, Dominguez RV, Abate SM, Abdelmasseh M, Abdoli A, Abdoli G, Abedi A, Abedi V, Abegaz TM, Abidi H, Aboagye RG, Abolhassani H, et al. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis. 2022 Nov;22(11):1626-1647.
111- Cousin E, Duncan BB, Stein C, Ong KL, Vos T, Abbafati C, Abbasi-Kangevari M, Abdelmasseh M, Abdoli A, Abd-Rabu R, Abolhassani H, et al. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 2022 Mar;10(3):177-192.
112- Tran KB, Lang JL, Compton K, Xu R, Acheson AR, Henrikson HJ, Kocarnik JM, Penberthy L, Aali A, Abbas Q, Abbasi B, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdelmasseh M, Abd-Elsalam A, Abdelwahab AA, Abdoli G, Abdulkadir H, Abedi A, Abegaz KH, Abidi H, Aboagye RG, Abolhassani H, et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Aug 20;400(10352):563-591.
113- Ledesma JR, Ma J, Vongpradith A, Maddison ER, Novotney A, Biehl MH, LeGrand KE, Ross JM, Jahagirdar D, Bryazka D, Feldman R, Abolhassani H, et al. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis.2022; 22(2):222-241.
114- Frostad JJ, Nguyen QP, Baumann MM, Blacker BF, Marczak LB, Deshpande A, Wiens KE, LeGrand KE, Johnson KB, Abbasi-Kangevari M, Abdoli A, Abolhassani H, et al. Mapping development and health effects of cooking with solid fuels in low-income and middle-income countries, 2000–18: a geospatial modelling study. Lancet Glob Health 2022; 10: e1395–411.
115- Dimitrova D, Nademi Z, Maccari ME, Ehl S, Uzel G, Tomoda T, Okano T, Imai K, Carpenter B, Ip W, Rao K, Worth AJJ, Laberko A, Mukhina A, Néven B, Moshous D, Speckmann C, Warnatz K, Wehr C, Abolhassani H, Aghamohammadi A, Bleesing JJ, Dara J, Dvorak CC, Ghosh S, Kang HJ, Markelj G, Modi A, Bayer DK, Notarangelo LD, Schulz A, Garcia-Prat M, Soler-Palacín P, Karakükcü M, Yilmaz E, Gambineri E, Menconi M, Masmas TN, Holm M, Bonfim C, Prando C, Hughes S, Jolles S, Morris EC, Kapoor N, Koltan S, Paneesha S, Steward C, Wynn R, Duffner U, Gennery AR, Lankester AC, Slatter M, Kanakry JA. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. J Allergy Clin Immunol. 2022 Jan;149(1):410-421.
116- Zhang Q, Matuozzo D, Le Pen J, Lee D, Moens L, Asano T, Bohlen J, Liu Z, Moncada-Velez M, Kendir-Demirkol Y, Jing H, Bizien L, Marchal A, Abolhassani H, Delafontaine S, Bucciol G; COVID Human Genetic Effort, Bayhan GI, Keles S, Kiykim A, Hancerli S, Haerynck F, Florkin B, Hatipoglu N, Ozcelik T, Morelle G, Zatz M, Ng LFP, Lye DC, Young BE, Leo YS, Dalgard CL, Lifton RP, Renia L, Meyts I, Jouanguy E, Hammarström L, Pan-Hammarström Q, Boisson B, Bastard P, Su HC, Boisson-Dupuis S, Abel L, Rice CM, Zhang SY, Cobat A, Casanova JL. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. Journal of Experimental Medicine. 2022. Aug 1;219(8):e20220131.
117- Bastard P, Vazquez S, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K; COVID HGE consortium †; French COVID study group †; COMET consortium †, Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Keles S, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova JL, DeRisi JL. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol. 2022 Jun 14:eabp8966.
118- Ogishi M, Arias AA, Yang R, Han JE, Zhang P, Rinchai D, Halpern J, Mulwa J, Keating N, Chrabieh M, Lainé C, Seeleuthner Y, Ramírez-Alejo N, Nekooie-Marnany N, Guennoun A, Muller-Fleckenstein I, Fleckenstein B, Kilic SS, Minegishi Y, Ehl S, Kaiser-Labusch P, Kendir-Demirkol Y, Rozenberg F, Errami A, Zhang SY, Zhang Q, Bohlen J, Philippot Q, Puel A, Jouanguy E, Pourmoghaddas Z, Bakhtiar S, Willasch AM, Horneff G, Llanora G, Shek LP, Chai LYA, Tay SH, Rahimi HH, Mahdaviani SA, Nepesov S, Bousfiha AA, Erdeniz EH, Karbuz A, Marr N, Navarrete C, Adeli M, Hammarstrom L, Abolhassani H*, Parvaneh N, Al Muhsen S, Alosaimi MF, Alsohime F, Nourizadeh M, Moin M, Arnaout R, Alshareef S, El-Baghdadi J, Genel F, Sherkat R, Kiykim A, Yücel E, Keles S, Bustamante J, Abel L, Casanova JL, Boisson-Dupuis S.. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. Journal of Experimental Medicine. 2022. J Exp Med. 2022 Oct 3;219(10):e20220094.
119- Vlachiotis S, Abolhassani H*. Transcriptional regulation of B cell class-switch recombination: the role in development of non-infectious complications. Expert Rev Clin Immunol. 2022 Nov;18(11):1145-1154.
120- Wang Y, Abolhassani H*. Updates of Cancer Hallmarks in Patients with Inborn Errors of Immunity. Curr Opin Allergy Clin Immunol. 2022 Dec 1;22(6):352-363.
121- Sefer AP, Abolhassani H, Ober F, Kayaoglu B, Bilgic Eltan S, Kara A, Erman B, Surucu Yilmaz N, Aydogmus C, Aydemir S, Charbonnier Lm, Kolukisa B, Azizi G, Delavari S, Momen T, Aliyeva S, Kendir Demirkol Y, Tekin S, Kiykim A, Baser Of, Cokugras H, Gursel M, Karakoc-aydiner E, Ozen A, Krappmann D, Chatila Ta, Rezaei N, Baris S. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency. J Clin Immunol. 2022. Apr;42(3):634-652.
122- Fekrvand S, Delavari S, Chavoshzadeh Z, Sherkat R, Mahdaviani SA, Sadeghi Shabestari M, Azizi G, Arzanian MT, Shahin Shamsian B, Eskandarzadeh S, Eslami N, Rae W, Condino-Neto A, Mohammadi J, Abolhassani H, Yazdani R, Aghamohammadi A. The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS). Immunol Invest. 2022. Apr;51(3):644-659.
123- Fathi N, Saadati A, Alimohammadi M, Abolhassani H, Sharifi S, Rezaei N, Hassanzadeh M. Biosensors for the detection of protein kinases: Recent progress and challenges. Microchemical Journal. 2022. 182 (2022) 107961.
124- Zarezadeh Mehrabadi A, Aghamohamadi N, Abolhassani H, Aghamohammadi A, Rezaei N, Yazdani R. Comprehensive Assessment of Skin Disorders in Patients with Common Variable Immunodeficiency (CVID). J Clin Immunol. 2022. Apr;42(3):653-664.
125- Sepanlou SG, Rezaei Aliabadi H, Abbasi-Kangevari M, Abolhassani H, et al. GBD Child Mortality in Middle East Collaborators. Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019. Arch Iran Med. December 2022;25(12):767-778.
126- Sepanlou SG, Rezaei Aliabadi H, Rezaei N, Abbasi-Kangevari M, Abolhassani H, et al. GBD 2019 Iran Child Collaborators. Neonate, Infant, and Child Mortality by Cause in Provinces of Iran: An Analysis for the Global Burden of Disease Study 2019. Arch Iran Med. 2022 Aug 1;25(8):484-495
127- Sepanlou SG, Rezaei Aliabadi H, Rezaei N, Abbasi p, Abbasifard M, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abolhassani H, et al. GBD 2019 Iran Maternal Collaborators. Maternal Mortality and Morbidity by Cause in Provinces of Iran, 1990 to 2019: An Analysis for the Global Burden of Disease Study 2019. Arch Iran Med. 2022 Sep 1;25(9):578-590.
128- Khanmohammadi S, Shad TM, Delavari S, Shirmast P, Bagheri Y, Azizi G, Aghamohammadi A, Abolhassani H, Yazdani R, Rezaei N. Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia. Endocr Metab Immune Disord Drug Targets.2022;22(6):640-649.
129- Tavakol M, Delavari S, Salami F, Ansari S, Rasouli SE, Chavoshzadeh Z, Sherkat R, Ahanchian H, Aleyasin S, Esmaeilzadeh H, Moazzen N, Shafiei A, Abolnezhadian F, Iranparast S, Ebrahimi SS, Moeini Shad T, Pashangzadeh S, Nazari F, Rezaei A, Saeedi-Boroujeni A, Nabavi M, Arshi S, Fallahpour M, Bemanian MH, Sharafian S, Shokri S, Eshaghi S, Nazari S, Shamsian BS, Dargahi Mal-Amir M, Khazaei R, Ashkevari P, Khavandegar A, Haghi S, Esmaeili M, Abolhassani H, Rezaei N. Diversity of malignancies in patients with different types of inborn errors of immunity. Allergy Asthma Clin Immunol. 2022 Dec 12;18(1):106.
130- Salami F, Fekrvand S, Yazdani R, Shahkarami S, Azizi G, Bagheri Y, Delavari S, Shariati S, Mahdaviani SA, Abolhassani H, Samadi M, Aghamohammadi A. Evaluation of expression of LRBA and CTLA-4 proteins in Common variable immunodeficiency patients. Immunol Invest. 2022;51(2):381-394.
131- Salami F, Shariati S, Rasouli SE, Delavari S, Tavakol M, Sadri H, Asghari B, Yazdani R, Rezaei N, Abolhassani H, Azizi G. The Effects of Stimulation with PMA/Ionomycin on CD4+ T cell Proliferation and Surface CD4 Molecule Modulation of Patients with LRBA Deficiency and CVID with the Unsolved Genetic Defect. Endocr Metab Immune Disord Drug Targets. 2022.;22(5):539-544.
132- Soltani M, Rezaei M, Fekrvand S, Ganjalikhani-Hakemi M, Abolhassani H, Yazdani R. Role of Rare Immune Cells in Common Variable Immunodeficiency. Pediatr Allergy Immunol. 2022 Feb;33(2):e13725.
133- Fang M*, Su Z*, Abolhassani H*, Zhang W, Jiang C, Cheng B, Luo L, Wu J, Wang S, Lin L, Wang X, Wang L, Aghamohammadi A, Li T, Zhang X, Hammarström L, Liu X. T cell repertoire abnormality in immunodeficiency patients with DNA repair and methylation defects. J Clin Immunol. 2022;42(2):375-393.
134- Mohtashami M, Razavi A, Abolhassani H, Aghamohammadi A, Yazdani R. Primary Immunodeficiency and Thrombocytopenia. Int Rev Immunol. 2022;41(2):135-159.
135- Bagheri Y, Saeidi M, Yazdani R, Babaha F, Falak R, Azizi G, Taherian M, Salami F, Yazdani Y, Sadani S, Hosseini A, Motallebnezhad M, Abolhassani H, Shekarabi M, Aghamohammadi A. Evaluation of effective factors on IL-10 signaling in B cells in selective IgA deficiency patients. Eur Cytokine Netw. 2022 Mar 1;33(1):1-12.
136- Sharifinejad N, Azizi G, Behniafard N, Zaki-Dizaji M, Jamee M, Yazdani R, Abolhassani H, Aghamohammadi A. Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature. Immunol Invest. 2022;51(2):331-342.
137- Amirifar P, Mehrmohamadi M, Ranjouri MR, Akrami SM, Rezaei N, Saberi A, Yazdani R, Abolhassani H*, Aghamohammadi A. Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients. J Clin Immunol. 2022;42(1):72-84.
138- Tofighi Zavareh F, Mirshafiey A, Yazdani R, Keshtkar AA, Abolhassani H, Mahdaviani SA, Habibi S, Sohani M, Rezaei N, Aghamohammadi A.Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects. Scand J Immunol. 2022 Jul;96(1):e13164.
139- Sharifinejad N, Zaki-Dizaji M, Sepahvandi R, Fayyaz F, Vilela MMDS, ElGhazali G, Abolhassani H, Ochs HD, Azizi G. The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review. Clin Exp Immunol. 2022 Jun 23;208(3):281-291.
140- Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, Kumagai-Braesh M, Andréll J, Percivalle E, Sammartino JC, Wang Y, Vlachiotis S, Attevall J, Bergami F, Ferrari A, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Asperges E, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Calzolai L, Varani L, Hust M, Xue Y, Hammarström L, Baldanti F, Pan-Hammarström Q. Immunity to SARS-CoV-2 up to 15 months after infection. iScince. 2022. 25(2):103743.
141- Fekrvand S, Khanmohammadi S, Abolhassani H, Yazdani R. B-and T-cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency. Front Immunol. 2022 Jun 15;13:912826.
142- Fliegauf M, Kinnunen M, Posadas-Cantera S, Camacho-Ordonez N, Abolhassani H, Alsina L, Atschekzei F, Bogaert DJ, Burns SO, Church JA, Dückers G, Freeman AF, Hammarström L, Hanitsch LG, Kerre T, Kobbe R, Sharapova SO, Siepermann K, Speckmann C, Steiner S, Verma N, Walter JE, Westermann-Clark E, Goldacker S, Warnatz K, Varjosalo M, Grimbacher B.. Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50. Front Immunol. 2022 Aug 29;13:965326.
143- Azangou-Khyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, Rashidi M, Mohammadi E, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abolhassani H, et al. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. Sci Rep. 2022 Aug 2;12(1):13231.
144- Edwards E, Ameratunga R, Abolhassani H, Maglione PJ. Editorial: Contemporary Challenges in Diagnosis and Treatment of Predominantly Antibody Deficiency. Front Immunol. 2022 Aug 15;13:959720.
145- Wang Y, Abolhassani H, Hammarström L, Pan-Hammarström Q. SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects. Acta Biochimica et Biophysica Sinica. 2022 Jun 25;54(6):836-846.
146- Fang M, Su Z, Abolhassani H, Itan Y, Jin X, Hammarström L. VIPPID: a gene-specific single nucleotide variant pathogenicity prediction tool for Primary Immunodeficiency Diseases. Brief Bioinform. 2022 Sep 20;23(5):bbac176.
147- Maródi L, Abolhassani H, J Project Study group et al. A rose amongst the thorns: the mission of the J Project in a conflictual world. J Clin Immunol. 2022 Aug;42(6):1151-1155.
148- Ye X, Maglione PJ, Wehr C, Li X, Wang Y, Abolhassani H, Deripapa E, Liu D, Borte S, Du L, Wan H, Plötner A, Giannoula Y, Ko HM, Hou Y, Zhu S, Grossman JK, Sander B, Grimbacher B, Hammarström L, Fedorova A, Rosenzweig S, Shcherbina A, Wu K, Warnatz K, Cunningham-Rundles C, Pan-Hammarström Q et al. Genomic characterization of lymphomas in patients with inborn errors of immunity. Blood Adv. 2022 Sep 27;6(18):5403-5414.
149- Geier CB, Ellison M, Cruz R, Pawar S, Leiss-Piller A, Zmajkovicova K, McNulty SM, Yilmaz M, Evans MO 2nd, Gordon S, Ujhazi B, Wiest I, Abolhassani H, et al. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients. J Clin Immunol. 2022 Nov;42(8):1748-1765.
150- Abolhassani H, Landegren N, Bastard P, Materna M, Modaresi M, Du L, Aranda-Guillén M, Sardh F, Zuo F, Zhang P, Marcotte H, Marr N, Khan T, Ata M, Al-Ali F, Pescarmona R, Belot A, Béziat V, Zhang Q, Casanova JL, Kämpe O, Zhang SY, Hammarström L, Pan-Hammarström Q. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome. J Clin Immunol. 2022 Apr;42(3):471-483.
151- Abolhassani H, Vosughimotlagh A, Asano T, Landegren N, Boisson B, Delavari S, Bastard P, Aranda-Guillén M, Wang Y, Zuo F, Sardh F, Marcotte H, Du L, Zhang SY, Zhang Q, Rezaei N, Kämpe O, Casanova JL, Hammarström L, Pan-Hammarström Q. X-linked TLR7 deficiency underlies critical COVID-19 pneumonia in a male patient with ataxia-telangiectasia. J Clin Immunol. 2022. 42(1):1-9.
152- Paulson KR, Kamath AM, Alam T, Bienhoff K, Abady GG, Abbas J, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abd-Elsalam SM, Abdoli A, Abedi A, Abolhassani H, et al. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet. 2021 Sep 4;398(10303):870-905.
153- Sbarra AN, Rolfe S, Nguyen JQ, Earl L, Galles NC, Marks A, Abbas KM, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M, Abegaz KH, Abiy HA, Abolhassani H, et al. Mapping routine measles vaccination in low- and middle-income countries. Nature. 2021 Jan;589(7842):415-419.
154- Galles NC, Liu PY, Updike RL, Fullman N, Nguyen J, Rolfe S, Sbarra AN, Schipp MF, Marks A, Abady GG, Abbas KM, Abbasi SW, Abbastabar H, Abd-Allah F, Abdoli A, Abolhassani H, et al. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet. 2021 Aug 7;398(10299):503-521.
155- Delavari S, Abolhassani H#*, et al. Impact of SARS CoV-2 Pandemic on Patients with Primary Immunodeficiency. J Clin Immunol. 2021 Feb;41(2):345-355.
156- Amirifar P, Ranjouri MR, Pashangzadeh S, Lavin M, Yazdani R, Shad TM, Mehrmohamadi M, Salami F, Delavari S, Moamer S, Aghamohammadi A, Akrami SM, Abolhassani H*. The spectrum of ATM gene mutations in Iranian patients with ataxia-telangiectasia. Pediatr Allergy Immunol. 2021 Aug;32(6):1316-1326.
157- Micah AE, Cogswell IE, Cunningham B, Ezoe S, Harle AC, Maddison ER, McCracken D, Nomura S, Simpson KE, Stutzman HN, Tsakalos G, Wallace LE, Zhao Y, Zende RR, Abbafati C, Abdelmasseh M, Abedi A, Abegaz KH, Abhilash ES, Abolhassani H, et al. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. Lancet. 2021 Oct 9;398(10308):1317-1343.
158- Pillay BA, Fusaro M, Gray PE, Statham AL, Burnett L, Bezrodnik L, Kane A, Tong WWY, Abdo C, Winter S, Chevalier S, Levy R, Masson C, Schmitt Y, Bole-Feysot C, Malphettes M, Macintyre E, de Villartay JP, Ziegler JB, Smart JM, Peake J, Aghamohammadi A, Hammarström L, Abolhassani H, Picard C, Fischer A, Latour S, Neven B, Tangye S, Ma CS. Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency. J Clin Invest. 2021 Feb 1;131(3):e142434.
159- Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, Ozen A, Baris S, Karakoc-Aydiner E, Kilic SS, Kose H, Gulez N, Genel F, Reisli I, Djenouhat K, Tahiat A, Boukari R, Ladj S, Belbouab R, Ferhani Y, Belaid B, Djidjik R, Kechout N, Attal N, Saidani K, Barbouche R, Bousfiha A, Sobh A, Rizk R, Elnagdy MH, Al-Ahmed M, Al-Tamemi S, Nasrullayeva G, Adeli M, Al-Nesf M, Hassen A, Mehawej C, Irani C, Megarbane A, Quinn J; MENA-I. E. I. Study Group, Maródi L, Modell V, Modell F, Al-Herz W, Geha RS, Abolhassani H*. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity. J Clin Immunol. 2021 Aug;41(6):1339-1351.
160- Moeini Shad T, Yazdani R, Amirifar P, Delavari S, Heidarzadeh Arani M, Mahdaviani SA, Sadeghi-Shabestari M, Aghamohammadi A, Rezaei N, Abolhassani H. Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature. Front. Immunol. 2021. 12:779502.
161- Neehus AL, Moriya K, Nieto-Patlán A, Le Voyer T, Lévy R, Özen A, Karakoc-Aydiner E, Baris S, Yildiran A, Altundag E, Roynard M, Haake K, Migaud M, Dorgham K, Gorochov G, Abel L, Lachmann N, Dogu F, Haskologlu S, İnce E, El-Benna J, Uzel G, Kiykim A, Boztug K, Roderick MR, Shahrooei M, Brogan PA, Abolhassani H, Hancioglu G, Parvaneh N, Belot A, Ikinciogullari A, Casanova JL, Puel A, Bustamante J. Impaired respiratory burst contributes to infections in PKCδ-deficient patients. J Exp Med. 2021 Sep 6;218(9):e20210501.
162- Català-Moll F, Ferreté-Bonastre AG, Li T, Weichenhan D, Lutsik P, Ciudad L, Álvarez-Prado ÁF, Rodríguez-Ubreva J, Klemann C, Speckmann C, Vilas-Zornoza A, Abolhassani H, Martínez-Gallo M, Dieli-Crimi R, Rivière JG, Martín-Nalda A, Colobran R, Soler-Palacín P, Kracker S, Hammarström L, Prosper F, Durandy A, Grimbacher B, Plass C, Ballestar E. Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction. Nucleic Acids Res. 2021 May 21;49(9):5057-5073.
163- Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, Zhang P, Meertens L, Bolze A, Materna M, Korniotis S, Gervais A, Talouarn E, Bigio B, Seeleuthner Y, Bilguvar K, Zhang Y, Neehus AL, Ogishi M, Pelham SJ, Le Voyer T, Rosain J, Philippot Q, Soler-Palacín P, Colobran R, Martin-Nalda A, Rivière JG, Tandjaoui-Lambiotte Y, Chaïbi K, Shahrooei M, Darazam IA, Olyaei NA, Mansouri D, Hatipoğlu N, Palabiyik F, Ozcelik T, Novelli G, Novelli A, Casari G, Aiuti A, Carrera P, Bondesan S, Barzaghi F, Rovere-Querini P, Tresoldi C, Franco JL, Rojas J, Reyes LF, Bustos IG, Arias AA, Morelle G, Christèle K, Troya J, Planas-Serra L, Schlüter A, Gut M, Pujol A, Allende LM, Rodriguez-Gallego C, Flores C, Cabrera-Marante O, Pleguezuelo DE, de Diego RP, Keles S, Aytekin G, Akcan OM, Bryceson YT, Bergman P, Brodin P, Smole D, Smith CIE, Norlin AC, Campbell TM, Covill LE, Hammarström L, Pan-Hammarström Q, Abolhassani H, Mane S, Marr N, Ata M, Al Ali F, Khan T, Spaan AN, Dalgard CL, Bonfanti P, Biondi A, Tubiana S, Burdet C, Nussbaum R, Kahn-Kirby A, Snow AL; COVID Human Genetic Effort; COVID-STORM Clinicians; COVID Clinicians; Imagine COVID Group; French COVID Cohort Study Group; CoV-Contact Cohort; Amsterdam UMC Covid-; Biobank; NIAID-USUHS COVID Study Group, Bustamante J, Puel A, Boisson-Dupuis S, Zhang SY, Béziat V, Lifton RP, Bastard P, Notarangelo LD, Abel L, Su HC, Jouanguy E, Amara A, Soumelis V, Cobat A, Zhang Q, Casanova JL. X-linked recessive TLR7 deficiency in 1% of men under 60 years with life-threatening COVID-19. Science Immunology. 2021 Aug 19;6(62):eabl4348.
164- Ebrahimi H, Aryan Z, Moghaddam SS, Bisignano C, Rezaei S, Pishgar F, Force LM, Abolhassani H, et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2021 Sep;9(9):1030-1049.
165- Kinyoki D, Osgood-Zimmerman AE, Bhattacharjee NV, Schaeffer LE, Lazzar-Atwood A, LuD, Ewald SB, Donkers KM, Letourneau ID, Collison M, Schipp MF, Abajobir A, Abbasi S, Abbasi N, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abd-Elsalam SM, Abdoli A, Abdollahpour I, Abedi A, Abolhassani H, et al. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nat Med. 2021 Oct;27(10):1761-1782.
166- Ward JL, Azzopardi PS, Francis KL, Santelli JS, Skirbekk V, Sawyer SM, Kassebaum NJ, Mokdad SH, Hay SI, Abd-Allah F, Abdoli A, Abdollahi M, Abedi A, Abolhassani H, et al. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021 Oct 30;398(10311):1593-1618.
167- Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen MRJ, Fischer A, Grimbacher B, Edgar D, Buckland M, Mahlaoui N, Ehl S; ESID Registry Working Party (Iran: Abolhassani H, Rezaei N, Aghamohammadi A). Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021 Nov;148(5):1332-1341.
168- Azizi G, Tavakol M, Yazdani R, Delavari S, Moeini Shad T, Rasouli SE, Jamee M, Pashangzadeh S, Kalantari A, Shariat M, Shafiei A, Mohammadi J, Hassanpour G, Chavoshzadeh Z, Mahdaviani SA, Momen T, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Alyasin S, Jabbari-Azad F, Ghaffari J, Mesdaghi M, Ahanchian H, Khoshkhui M, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Nasiri Kalmarzi R, Esmaeilzadeh H, Tafaroji J, Khalili A, Sadeghi-Shabestari M, Darougar S, Moghtaderi M, Ahmadiafshar A, Shakerian B, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Fallahpour M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahimi Haji-Abadi M, Ashournia P, Razaghian A, Rezaei A, Salami F, Shirmast P, Bazargan N, Mamishi S, Ali Khazaei H, Negahdari B, Shokri S, Nabavizadeh SH, Bazregari S, Ghasemi R, Bayat S, Eshaghi H, Rezaei N, Abolhassani H*, Aghamohammadi A. Autoimmune Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. 2021. Pediatr Allergy Immunol. 2021 Aug;32(6):1335-1348.
169- Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, Abolhassani H, Delavari S, Sohani M, Rezaei A, Hassanpour G, Akrami SM, Aghamohammadi A. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients. Immunol Invest. 2021 Feb;50(2-3):201-215.
170- Kiaee F, Zaki-Dizaji M, Hafezi N, Almasi-Hashiani A, Hamedifar H, Sabzevari A, Shirkani A, Zian Z, Jadidi-Niaragh F, Aghamahdi F, Goudarzvand M, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, Immunologic, and Molecular Spectrum of Patients with Immunodeficiency, Centromeric instability, and Facial anomalies (ICF) syndrome: a Systematic Review. Endocr Metab Immune Disord Drug Targets. 2021;21(4):664-672.
171- Esmaeilzadeh H, Askarisarvestani A, Hosseini N, Samimi S, Shafiei A, Mahdaviani SA, Eslami N, Chavoshzadeh Z, Fallahi M, Khakbazanfard N, Shabestari MS, Aleyasin S, Nabavizadeh SH, Cheraghi T, Kalantari A, Ahmadiafshar A, Safari M, Eslamian MH, Molatefi R, Shirkani A, Heidarzadeh M, Tavakol M, Bemanian MH, Arshi S, Nabavi M, Shokri S, Shahhosseini B, Mortazavi N, Nakhaei P, Nazari F, Fallahpour M, Ahanchian H, Moazzen N, Khoshkhui M, Motlagh AV, Aghamohammadi A, Abolhassani H, Yazdani R, Rezaei N. Adverse Reactions in a Large Cohort of Patients with Inborn Errors of Immunity Receiving Intravenous Immunoglobulin. Clin Immunol. 2021 Sep;230:108826.
172- Tofighi Zavareh F, Mirshafiey A, Yazdani R, Keshtkar AA, Abolhassani H, Bagheri Y, Rezaei A, Delavari S, Rezaei N, Aghamohammadi A. Lymphocytes subsets in correlation with clinical profile in CVID patients without monogenic defects. Expert Rev Clin Immunol. 2021 Sep;17(9):1041-1051.
173- Safarirad M, Ganji AA, Fekrvand S, Yazdani R, Motlagh AV, Abolhassani H, Aghamohammadi A. The First Case Report of Kabuki Syndrome from the National Iranian Registry of Primary Immunodeficiencies. Endocr Metab Immune Disord Drug Targets. 2021;21(11):2099-2103.
174- Amirifar P, Ranjouri MR, Abolhassani H, Moeini Shad T, Almasi-Hashiani A, Azizi G, Moamer S, Aghamohammadi A, Yazdani R. Clinical, Immunological and Genetic findings in Patients with UNC13D Deficiency (FHL3): a Systematic Review. Pediatr Allergy Immunol. 2021. Jan;32(1):186-197.
175- Babaha F, Yazdani R, Shahkarami S, Hamidi Esfahani Z, Abolhassani H, Sadr M, Zavaran Hosseini A, Aghamohammadi A. Evaluation of miR-210 Expression in Common Variable immunodeficiency Patients with Unsolved Genetic Defect. Allergologia et immunopathologia. 2021 Mar 1;49(2):84-93.
176- Hamidi Esfahani Z, Yazdani R, Shahkarami S, Babaha F, Abolhassani H, Sadr M, Pourfathollah AA, Aghamohammadi A.Evaluation of MicroRNA-125b-5p and transcription factors BLIMP1 and IRF4 Expression in Unsolved Common Variable Immunodeficiency Patients. Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):700-710.
177- Nejatbakhsh F, Zareian MA, Yaseliani M, Abolhassani H*. Evidence-Based Immunotherapeutic Effects of Herbal Compounds on Humoral Immunity; Ancient and New Approaches. Chin J Integr Med. 2021 Apr;27(4):313-320.
178- MoeiniShad T, Yousefi B, Amirifar P, Delavari S, Rae W, Kokhaei P, Abolhassani H, Aghamohammadi A, Yazdani R. Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia. J Clin Immunol. 2021 Jan;41(1):76-88.
179- Amirifar P, Yazdani R, Azizi G, Ranjouri MR, Durandy A, Plebani A, Lougaris V, Hammarstrom L, Aghamohammadi A, Abolhassani H*. Known and Potential Molecules Associated with Altered B cell Development Leading to Predominantly Antibody Deficiencies. Pediatr Allergy Immunol. 2021 Nov;32(8):1601-1615.
180- Khalili A, Yadegari AH, Delavari S, Yazdani R, Abolhassani H. Disseminated Intravascular Coagulation Associated with Large Deletion of Immunoglobulin Heavy Chain. Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):778-783.
181- Abolhassani H*, Wang Y, Hammarström L, Pan-Hammarström Q. Hallmarks of Cancers: Primary Antibody Deficiency versus Other Inborn Errors of Immunity. Front Immunol. 2021 Aug 17;12:720025.
182- Aghamohammadi A, Abolhassani H, Rezaei N. Primary Immunodeficiency Diseases in Iran: Past, Present and Future. Arch Iran Med. 2021 Feb 1;24(2):118-124.
183- Fekrvand S, Mozdarani H, Delavari S, Sohani M, Nazari F, Kiaee F, Bagheri Y, Azizi G, Hassanpour G, Mozdarani S, Abolhassani H, Aghamohammadi A, Yazdani R. Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome. Immunol Invest. 2021 Jul;50(5):580-596.
184- Hafezi N, Zaki-Dizaji M, Nirouei M, Asadi G, Sharifinejad N, Jamee M, Rasouli SE, Hamedifar H, Sabzevari A, Chavoshzadeh Z, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, Immunological, and Genetic Features in 780 Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-like diseases: A Systematic Review. Pediatr Allergy Immunol. 2021 Oct;32(7):1519-1532.
185- Sharifinejad N, Zaki-Dizaji M, Tebyanian S, Zainaldain H, Jamee M, Rizvi FS, Hosseinzadeh S, Fayyaz F, Hamedifar H, Sabzevari A, Matloubi M, Heropolitańska-Pliszka E, Aghamahdi F, Abolhassani H, Azizi G. Clinical, Immunological, and Genetic Features in 938 Patients with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED): a Systematic Review. Expert Rev Clin Immunol. 2021 Aug;17(8):807-817.
186- Darbeheshti F, Abolhassani H, Bashashati M, Ghavami S, Shahkarami S, Zoghi S, Gupta S, Orange JS, Ochs HD, Rezaei N. Coronavirus: Pure Infectious Disease or Genetic Predisposition. Adv Exp Med Biol. 2021;1318: 91-107.
187- Maródi L, Abolhassani H, J Project Study group et al. The 10th anniversary of the world primary immunodeficiency week: A J Project celebration. Eur J Immunol. 2021 Oct;51(10):2364-2366.
188- Karimi E, Mahmoudian F, Reyes SOL, Bargir UA, Madkaikar M, Artac H, Sabzevari A, Lu N, Azizi G, Abolhassani H*. Approach to Genetic Diagnosis of Inborn Errors of Immunity through Next-Generation Sequencing. Mol Immunol. 2021 Jun 30;137:57-66.
189- Sancho-Shimizu V, Brodin P, Cobat A, Biggs CM, Toubiana J, Lucas CL, Henrickson SE, Belot A; MIS-C@CHGE (Haddad, Beland, Pujol, Schlüter, Planas-Serra, Aguilera-Albesa, Valencia-Ramos, Rodríguez-Palmero, Gut, Rivière, Colobran, Soler-Palacin, Rodriguez-Gallego, Perez De Diego, Flores, Alsina, Blazquez-Gamero, Jordan, Keles, Emiroglu, Metin Akcan, Alkan, Aytekin, Gul, Tüter Öz, Bozdemir, Bayhan, Yüksek, Parlakay, Gülhan, Yahşi, Kilic, Karbuz, Erdeniz Özkan, Orbak, Aydemir, Celik, Kandemir, Aytekin, Kapakli, Yarar, Alper Yosunkaya, Vatansev, Aytekin, Torun, Nepesov, Coskuner, Sözeri, Demirkol, Kasapcopur, Yıldız, Sevketoglu, Hatipoğlu, Özçelik, Yesilbas, Aydin, Sediva, Klocperk, Bloomfield, Meyts, Delafontaine, Haerynck, Hoste, Shahrooei, Marque, Neves, Novelli, Novelli, Aiuti, Casari, Bousfiha, Almuhsen, Sobh, Gagro, Bajolle, Bonnet, Lebon, Lei, Lee, Seeleuthner, Zhang, Maglorius, Philippot, Pelham, Bastard, Zhang, Jouanguy, Puel, Herberg, Kuijpers, Bellos, Kaforou, Menikou, Pan-Hammarström, Hammarström, Abolhassani H, Bryceson, Condino-Neto, Prando, Bando, Cavalcanti, Fellay, Blanchard-Hohner, Mansouri, Mahmoudi, Boyarchuk, Volokha, Bondarenko, Stepanovskiy, Mogensen, van de Beek, Andreakos, Papadaki, Tayoun, Halwani, Al-Mulla, Franco, Lau, Kwan, Imai, Okada, Bolze, Butte, Hsieh, Drolet, Arkin, Itan, Maniatis, Arditi, Cooper, Schmitt, Chakravorty, Anderson, Su, Notarangelo), Tangye SG, Milner JD, Levin M, Abel L, Bogunovic D, Casanova JL, Zhang SY.SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?. J Exp Med. 2021 Jun 7;218(6):e20210446.
190- Safarirad M, Ganji AA, Nazari F, Yazdani R, Abolhassani H, Motlagh AV. Transient increased immunoglobulin levels in a hyper-IgM syndrome patient with COVID-19 infection. Allergol Immunopathol (Madr). 2021 Nov 1;49(6):63-66.
191- Sherina N, Piralla A, Du L, Wan H, Kumagai-Braesh M, Andréll J, Braesch-Andersen S, Cassaniti I, Percivalle E, Sarasini A, Bergami F, Di Martino R, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Byrne-Steele M, Han J, Hust M, Xue Y, Hammarström L, Baldanti F, Marcotte H, Pan-Hammarström Q. Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection. Med. 2021.12;2(3):281-295.
192- Abolhassani H*. Specific Immune Response and Cytokine Production in CD70 deficiency. Front Pediatr. 2021. Apr 30;9:615724.
193- Abolhassani H, Hammarström L, Cunningham-Rundles C. Current genetic landscape of CVID. Blood. 2020 Feb 27;135(9):656-667.
194- Micah AE, Su Y, Bachmeier SD, Chapin A, Cogswell IE, Crosby SW, Cunningham B, Harle AC, Maddison ER, Moitra M, Sahu M, Schneider MT, Simpson KE, Stutzman HN, Tsakalos G, Zende RR, Zlavog BS, Abbafati C, Abebo ZH, Abolhassani H, et al. Health Sector Spending and Spending on HIV/AIDS, Tuberculosis, and Malaria, and Development Assistance for Health: Progress Towards Sustainable Development Goal 3. Lancet. 2020 5-11 Sep;396(10252):693-724.
195- Ghosh S, Köstel Bal S, Edwards ESJ, Pillay B, Jimenez-Heredia R, Rao G, Erol Cipe F, Salzer E, Zoghi S, Abolhassani H, et al. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood. 2020 Dec 3;136(23):2638-2655.
196- Lozano R, Fullman N, Mumford JE, Knight M, Barthelemy CM, Abbafati C, Abbastaba Hr, Abd-Allah F, Abdollahi M, Abedi A, Abolhassani H, et al. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1250-1284.
197- Etemadi A, Safiri S, Sepanlou S, Ikuta K, Bisignano C, Shakeri R, Amani M, Fitzmaurice M, Nixon M, Abbasi N, Abolhassani H, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. The Lancet Gastroenterology & Hepatology. 2020 Jan;5(1):42-54.
198- Kinyoki DK, Ross JM, Lazzar-Atwood A, Munro SB, Schaeffer LE, Abbasalizad-Farhangi M, Abbasi M, Abbastabar H, Abdelalim A, Abdoli A, Abdollahi M, Abdollahpour I, Abdulkader RS, Abebe ND, Abebo TA, Abegaz KH, Abolhassani H, et al. Mapping Local Patterns of Childhood Overweight and Wasting in Low- And Middle-Income Countries Between 2000 and 2017. Nat Med. 2020 May;26(5):750-759.
199- Alatab S, Sepanlou S, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon M, Abdoli A, Abolhassani H, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology. 2020 Jan;5(1):17-30.
200- Abolhassani H, El-Sherbiny Y, Arumugakani G, Carter C, Richards S, Lawless D, Wood P, Buckland M, Heydarzadeh M, Aghamohammadi A, Hambleton S, Hammarström L, Burns S, Doffinger R, Savic S. Expanding clinical phenotype and novel insights into pathogenesis of ICOS deficiency. J Clin Immunol. 2020 Feb;40(2):277-288.
201- Tesch VK, Abolhassani H, Shadur B, Zobel J, Mareika Y, Sharapova S, Karakoc-Aydiner E, Rivière J, Garcia-Prat M, Moes N, Haerynck F, Gonzales- Granado L, Pérez JL, Mukhina A, Shcherbina A, Aghamohammadi A, Hammarström L, Dogu F, Haskologlu S, İkincioğulları A, Bal S, Baris S, Kilic S, Karaca NE, Kutukculer N, Girschick H, Kolios A, Keles S, Uygun V, Stepensky P, Worth A, van Montfrans J, Peters A, Meyts I, Adeli M, Marzollo A, Nurcicek P, Khojah A, Chavoshzadeh Z, Stefanija MA, Bakhtiar S, Florkin B, Meeths M, Gamez L, Grimbacher B, Seppänen M, Lankester A, Gennery AR, Seidel M. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol. 2020. May;145(5):1452-1463.
202- Abolhassani H, Lim CK, Aghamohammadi A, Hammarström L. Histocompatibility Complex Status and Mendelian Randomization Analysis in Unsolved Antibody Deficiency. Front Immunol. Front Immunol. 2020 Jan 24;11:14.
203- Rizvi FS, Zainaldain H, Rafiemanesh H, Jamee M, Hossein-Khannazer N, Hamedifar H, Sabzvari A, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Autoimmunity in Common Variable Immunodeficiency: A Systematic Review and Meta-Analysis. Expert Rev Clin Immunol. 2020 Dec;16(12):1227-1235.
204- Salami F, Shirkani A, Shahrooei M, Azizi G, Yazdani R, Abolhassani H, Aghamohammadi A. Leishmaniasis and autoimmunity in patient with LPS-responsive beige-like anchor protein (LRBA) deficiency. Endocr Metab Immune Disord Drug Targets. 2020;20(3):479-484.
205- Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, Aghamahdi F, Abolhassani H, Condliffe AM, Aghamohammadi A, Azizi G. Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review. Clin Rev Allergy Immunol. 2020. Dec;59(3):323-333.
206- Tavakol M, Jamee M, Azizi G, Sadri H, Bagheri Y, Zaki-Dizaji M, Mahdavi FS, Jadidi-Niaragh F, Tajfirooz S, Kamali AN, Aghamahdi F, Noorian S, Kojidi HT, Mosavian M, Matani R, Dolatshahi E, Porrostami K, Elahimehr N, Fatemi-Abhari M, Sharifi L, Arjmand R, Haghi S, Zainaldain H, Yazdani R, Shaghaghi M, Abolhassani H, Aghamohammadi A. Diagnostic Approach to The Patients with Suspected Primary Immunodeficiency. Endocr Metab Immune Disord Drug Targets. 2020;20(2):157-171.
207- Amirifar P, Yazdani R, MoeiniShad T, Ghanadan A, Abolhassani H, Lavin M, Sotoudeh S, Aghamohammadi A. Cutaneous granulomatosis and class switching defect as a presenting sign in Ataxia-Telangiectasia: First case from the national Iranian registry and review of the literature. Immunol Invest. 2020. Sep;49(6):597-610.
208- Yazdani R, Habibi S, Sharifi L, Azizi G, Abolhassani H, Olbrich P, Aghamohammadi A. Common Variable Immunodeficiency: Epidemiology, Pathogenesis, Clinical manifestations, Diagnosis, Classification and Management. J Investig Allergol Clin Immunol. 2020;30(1):14-34.
209- Ramzi N, Jamee M, Bakhtiyari M, Rafiemanesh H, Zainaldain H, Tavakol M, Rezaei A, Kalvandi M, Zian Z, Mohammadi H, Jadidi F, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Bronchiectasis in Common Variable Immunodeficiency: A Systematic Review and Meta-Analysis. Pediatric Pulmonology. 2020. Feb;55(2):292-299.
210- Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig S, Condino-Neto A, Azizi G, Rafiemanesh H, Hassanpour G, Rezaei N, Abolhassani H, Aghamohammadi A. Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1371-1386.
211- Moazzami B, Mohayeji Nasrabadi MA, Abolhassani H, Olbrich P, Azizi G, Shirzadi R, Modaresi M, Sohani M, Delavari S, Shahkarami S, Yazdani R, Aghamohammadi A. Comprehensive assessment of respiratory complications in patients with common variable immunodeficiency. Ann Allergy Asthma Immunol. 2020 May;124(5):505-511.
212- Zaki-Dizaji M, Tajdini M, Kiaee F, Shojaaldini H, Shervin-Badv R, Abolhassani H, Aghamohammadi A. Dystonia in Ataxia Telangiectasia: Case Report with Novel Mutations. Oman Med J. 2020 Feb 17;35(1):e93.
213- Fekrvand S, Yazdani R, Olbrich P, Azizi G, Shirzadi R, Modaresi M, Sohani M, Delavari S, Kalantari A, Shariat M, Shafiei A, Lu N, Hassanpour G, Rahimi Hajiabadi M, Ashournia P, Razaghian A, Asgharyan M, Shahraki-Ghadimi Z, Rouhani R, Hoda Fallah F, Rezaei N, Abolhassani H, Aghamohammadi A. Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia. Pediatr Allergy Immunol. 2020 May;31(4):405-417.
214- Dezfouli M, Bergström S, Skattum L, Abolhassani H, et al. Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies. Front Immunol. 2020 Mar 17;11:455.
215- Fekrvand S, Abolhassani H, Delavari S, Yazdani R, Aghamohammadi A. Asthma and allergic diseases are a phenotypic marker for CVID patients? Ann Allergy Asthma Immunol. 2020 Jun;124(6):636.
216- Abolhassani H, Marcotte H, Fang M, Hammarström L. Clinical Implications of Experimental Analyses of AID Function on Predictive Computational Tools: Challenge of Missense Variants. Clin Genet. 2020 Jun;97(6):844-856.
217- Pashangzadeh S, Yazdani R, Nazari F, Azizi G, Abolhassani H, Aghamohammadi A. Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Endocr Metab Immune Disord Drug Targets. 2020;20(9):1434-1447.
218- Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, Camacho-Ordonez N, Varjosalo M, Kinnunen M, de Vries E, van der Meer JWM, Ameratunga R, Roifman CM, Schejter YD, Kobbe R, Hautala T, Atschekzei F, Schmidt RE, Schröder C, Stepensky P, Shadur B, Pedroza LA, van der Flier M, Martínez-Gallo M, Gonzalez-Granado LI, Allende LM, Shcherbina A, Kuzmenko N, Zakharova V, Neves JF, Svec P, Fischer U, Ip W, Bartsch O, Barış S, Klein C, Geha R, Chou J, Alosaimi M, Weintraub L, Boztug K, Hirschmugl T, Dos Santos Vilela MM, Holzinger D, Seidl M, Lougaris V, Plebani A, Alsina L, Piquer-Gibert M, Deyà-Martínez A, Slade CA, Aghamohammadi A, Abolhassani H, Hammarström L, Kuismin O, Helminen M, Allen HL, Thaventhiran JE, Freeman AF, Cook M, Bakhtiar S, Christiansen M, Cunningham-Rundles C, Patel NC, Rae W, Niehues T, Brauer N, Syrjänen J, Seppänen MRJ, Burns SO, Tuijnenburg P, Kuijpers TW; NIHR-BioResource – Rare Diseases Consortium, Warnatz K, Grimbacher B. Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020. Oct;146(4):901-911.
219- Kamangar F, Nasrollahzadeh D, Safiri S, Sepanlou S, Fitzmaurice C, Ikuta K, Bisignano C, Islami F, Roshandel G, Lim S, Abolhassani H, et al.The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597.
220- Sohani M, Habibi S, Delavari S, Shahkarami S, Yazdani R; Shirmast P, Nazari F, Moeini Shad T, Mamishi S, Azizi G, Anka AU, Hassanpour G, Kalantari A, Shariat M, Shafiei A, Abolhassani H, Aghamohammadi A. Evaluation of Patients with Primary Immunodeficiency associated with Bacille Calmette-Guerin (BCG)-vaccine-derived complications. Allergol Immunopathol. 2020 Nov-Dec;48(6):729-737.
221- Hammarström L, Abolhassani H, Baldanti F, Marcotte H, Pan-Hammarström Q. Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients - a perspective. J Allergy Clin Immunol. 2020 Jul;146(1):58-60.
222- Mahnaz Jamee 1, Majid Zaki-Dizaji 2, Bernice Lo 3, Hassan Abolhassani 4, Fatemeh Aghamahdi 5, Mehdi Mosavian 5, Zohreh Nademi 6, Hamed Mohammadi 5, Farhad Jadidi-Niaragh 7, Manuel Rojas 8, Juan-Manuel Anaya 8, Gholamreza Azizi. Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2747-2760.
223- Sharifinejad N, Jamee M, Zaki-Dizaji M, Lo B, Shaghaghi M, Mohammadi H, Jadidi-Niaragh F, Shaghaghi S, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, Immunological, and Genetic Features in 49 Patients With ZAP-70 Deficiency: A Systematic Review. Front Immunol. 2020; 11: 831.
224- Asgardoon MH, Azizi G, Yazdani R, Sohani M, Pashangzadeh S, Kalantari A, Shariat M, Shafiei A, Salami F, Jamee M, Rasouli SE, Mohammadi J, Hassanpour G, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Alyasin S, Jabbari-Azad F, Ghaffari J, Mesdaghi M, Ahanchian H, Khoshkhui M, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Nasiri Kalmarzi R, Esmaeilzadeh H, Tafaroji J, Khalili A, Sadeghi-Shabestari M, Darougar S, Moghtaderi M, Ahmadiafshar A, Shakerian B, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Fallahpour M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahimi Haji-Abadi M, Ashournia P, Razaghian A, Rezaei A, Delavari S, Shirmast P, Babaha F, Samavat A, Mamishi S, Khazaei HA, Negahdari B, Rezaei N, Abolhassani H, Aghamohammadi A. Monogenic Primary Immunodeficiency Disorders Associated with Common Variable Immunodeficiency and Autoimmunity. Int Arch Allergy Immunol. 2020;181(9):706-714.
225- Maródi L, Abolhassani H, et al. The Konya Declaration for Patients with Primary Immunodeficiencies. J Clin Immunol. 2020 Jul;40(5):770-773.
226- Babaha F#, Abolhassani H#, Hamidi Esfahani Z, Yazdani R, Aghamohammadi A. A New Case of Congenital Ficolin-3 Deficiency with Primary Immunodeficiency. Expert Rev Clin Immunol. 2020 Jul;16(7):733-738.
227- Amirifar P, Ranjouri MR, Lavin M, Abolhassani H, Yazdani R, Aghamohammadi A. Ataxia-telangiectasia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Expert Rev Clin Immunol. 2020 Sep;16(9):859-871.
228- Zainaldain H, Rizvi FS, Rafiemanesh H, Alizadeh M, Jamee M, Mohammadi S, Kiaee F, Mohammadi H, Babaie F, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis. Oman Med J. 2020 Jul 30;35(4):e157.
229- Abolhassani H, Azizi G, Sharifi L, Yazdani R, Mohsenzadegan M, Delavari S, Sohani M, Shirmast P, Chavoshzadeh Z, Mahdaviani SA, Kalantari A, Tavakol M, Jabbari-Azad F, Ahanchian H, Momen T, Sherkat R, Sadeghi-Shabestari M, Aleyasin S, Esmaeilzadeh H, Al-Herz W, Bousfiha AA, Condino-Neto A, Seppänen M, Sullivan KE, Hammarström L, Modell V, Modell F, Quinn J, Orange JS, Aghamohammadi A. Global Systematic Review of Primary Immunodeficiency Registries. Expert Rev Clin Immunol. 2020 Jul;16(7):717-732.
230- Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M, Abdollahpour I, Abedi A, Abedi P, Abegaz KH, Abolhassani H, et al. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1135-1159.
231- Wang H, Abbas KM, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abolhassani H, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1160-1203.
232- Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M, Abdollahpour I, Abolhassani H, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-1222.
233- Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, Abd-Allah F, Abdelalim A, Abdollahi M, Abdollahpour I, Abegaz KH, Abolhassani H, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1223-1249.
234- Abolhassani H, Aghamohammadi A, Fang M, Rezaei N, Jiang C, Liu X, Pan-Hammarström Q, Hammarström L. Clinical Implications of Systematic Phenotyping and Exome Sequencing in Patients with Primary Antibody Deficiency. Genetics in Medicine. 2019 Jan;21(1):243-251.
235- Yazdani R, Fekrvand S, Shahkarami S, Azizi G, Moazzami B, Abolhassani H, Aghamohammadi A. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol. 2019. Jan;198:19-30.
236- Yazdani R, Amirifar P, Abolhassani H, Azizi G, Parvaneh N, Rezaei N, Aghamohammadi A. UNC13D Deficiency Associated with Epileptic Seizures and Antibody Deficiency: The First Case from the Iranian National Registry. J Investig Allergol Clin Immunol. 2019 Apr;29(2):160-162.
237- Azizi G, Bagheri Y, Yazdani R, Zaki-Dizaji M, Jamee M, Jadidi-Niaragh F, Kamali AN, Abolhassani H, Aghamohammadi A. The profile of IL-4, IL-5, IL-10 and GATA3 in patients with LRBA deficiency and CVID with no known monogenic disease: Association with disease severity. Allergol Immunopathol. 2019. Mar - Apr;47(2):172-178.
238- Yazdani R, Abolhassani H#, Kiaee F, Habibi S, Azizi G, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Gharagozlou M, Movahedi M, Hamidieh AA, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari A, Mansouri M, Mesdaghi M, Babaie D, Ahanchian H, Khoshkhui M, Soheili H, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Tavassoli M, Kalmarzi RN, Mortazavi SH, Kashef S, Esmaeilzadeh H, Tafaroji J, Khalili A, Zandieh F, Sadeghi-Shabestari M, Darougar S, Behmanesh F, Akbari H, Zandkarimi M, Abolnezhadian F, Fayezi A, Moghtaderi M, Ahmadiafshar A, Shakerian B, Sajedi V, Taghvaei B, Safari M, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Bazregari S, Bazargan N, Fallahpour M, Khayatzadeh A, Javahertrash N, Bashardoust B, Zamani M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahim M, Ashournia P, Razaghian A, Rezaei A, Samavat A, Mamishi S, Khazaei HA, Mohammadi J, Negahdari B, Parvaneh N, Rezaei N, Lougaris V, Giliani S, Plebani A, Ochs HD, Hammarström L, Aghamohammadi A. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort. J Allergy Clin Immunol: In Practice. 2019.7(3), 864-878.
239- Lim CK, Abolhassani H#, Appelberg SK, Sundin M, Hammarström L. IL2RG hypomorphic mutation: identification of a novel pathogenic mutation in exon8 and a review of literature. Allergy Asthma Clin Immunol. 2019. Jan 5;15(2):1-8.
240- Arias-Fuenzalida J, Yu J, Abolhassani H, Du L, Custodio J, Pan-Hammarström, Generation of a human induced pluripotent stem cell line from a primary immunodeficient patient with CD70 mutation. Stem Cell Res. 2019 Dec;41:101612.
241- Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A. Ataxia‐telangiectasia: A review of clinical features and molecular pathology. Pediatr Allergy Immunol. 2019. May;30(3):277-288.
242- Mozdarani H, Kiaee F, Fekrvand S, Azizi G, Yazdani R, Zaki-Dizaji M, Mozdarani S, Mozdarani S, Nosrati H, Abolhassani H, Aghamohammadi A. G2-lymphocyte Chromosomal Radiosensitivity in Patients with LPS Responsive Beige-Like Anchor Protein (LRBA) Deficiency. Int J Radiat Biol. 2019. Jun;95(6):680-690.
243- Fekrvand S, Yazdani R, Abolhassani H, Ghaffari J, Aghamohammadi A. The First Purine Nucleoside Phosphorylase Deficiency Patient Resembling IgA Deficiency and a Review of the Literature. Immunol Invest. 2019. May;48(4):410-430.
244- Yazdani R, Hamidi Z, Babaha F, Azizi G, Fekrvand S, Abolhassani H, Aghamohammadi A. PIK3R1 Mutation Associated with Hyper IgM (APDS2 Syndrome): A Case Report and Review of the Literature. Endocr Metab Immune Disord Drug Targets. 2019;19(7):941-958.
245- Tavassoli M, Abolhassani H#, Yazdani R, Ghadami M, Azizi G, Abdolrahim-Poor-Heravi S, Moeinishad T, Kokabee M, Movahedi M, Abdshahzadeh H, Gharagozlou M, Rezaei N, Esmaeilzadeh H, Aleyasin S, Aghamohammadi A. The First Cohort of Iranian Patients with Hyper Immunoglobulin E Syndrome: A Long-Term Follow-up and Genetic Analysis. Pediatr Allergy Immunol. 2019. Jun;30(4):469-478.
246- Fang M, Abolhassani H, Pan-Hammarström Q, Sandholm E, Liu X, Hammarström L. Compound Heterozygous Mutations of IL2-inducible T-cell kinase in a Swedish patient: The importance of early genetic diagnosis. J Clin Immunol. 2019 Feb;39(2):131-134.
247- Farmer JR, Foldvari Z, Ujhazi B, De Ravin SS, Chen K, Bleesing JJH, Schuetz C, Al-Herz W, Abraham RS, Joshi AY, Costa-Carvalho BT, Buchbinder D, Booth C, Reiff A, Ferguson PJ, Aghamohammadi A, Abolhassani H, Puck JM, Adeli M, Cancrini C, Palma P, Bertaina A, Locatelli F, Di Matteo G, Geha RS, Kanariou MG, Lycopoulou E, Tzanoudaki M, Sleasman JW, Parikh S, Pinero G, Fischer BM, Dbaibo G, Unal E, Patiroglu T, Karakukcu M, Al-Saad KK, Dilley MA, Pai SY, Dutmer CM, Gelfand EW, Geier CB, Eibl MM, Wolf HM, Henderson LA, Hazen MM, Bonfim C, Wolska-Kuśnierz B, Butte MJ, Hernandez JD, Nicholas SK, Stepensky P, Chandrakasan S, Miano M, Westermann-Clark E, Goda V, Kriván G, Holland SM, Fadugba O, Henrickson SE, Ozen A, Karakoc-Aydiner E, Baris S, Kiykim A, Bredius R, Hoeger B, Boztug K, Pashchenko O, Neven B, Moshous D, Villartay JP, Bousfiha AA, Hill HR, Notarangelo LD, Walter JE. Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency. J Allergy Clin Immunol: In Practice. 2019. Jul - Aug;7(6):1970-1985.
248- Moradi L, Cheraghi T, Yazdani R, Azizi G, Rasouli S, Zavareh FT, Parvaneh L, Parvaneh N, Sohani M, Delavari S, Abolhassani H, Rezaei N, Aghamohammadi A. Mendelian susceptibility to mycobacterial disease: Clinical and immunological findings of patients suspected for IL12Rβ1 deficiency. Allergol Immunopathol. 2019 Sep - Oct;47(5):491-498.
249- Bagheri Y, Sanaei R, Yazdani R, Shekarabi M, Falak R, Mohammadi J, Abolhassani H, Aghamohammadi A. The Heterogeneous Pathogenesis of Selective IgA. Int Arch Allergy Immunol. 2019. 2019;179(3):231-246.
250- Parvaneh L, Sharifi N, Azizi G, Abolhassani H, Sharifi L, Mohebbi A, Bahraminia A, Delavari S, Alebouyeh M, Tajeddin E, Mohebbi SR, Yazdani R, Behniafard N, Aghamohammadi A. Infectious etiology of chronic diarrhea in patients with primary immunodeficiency diseases. Eur Ann Allergy Clin Immunol. 2019. 51(1):32-38.
251- Janssen LMA, van Hout RWNM, de Vries E, Pignata C, Cirillo E, Arkwright PD, Lougaris V, Buckland M, Garcia-Prat M, Soler-Palacin P, Ouederni M, Kralickova P, Abolhassani H, Hammerstrom L, Aghamohamamdi A, Santos-Pérez JL, Sobh A, van de Werff Ten Bosch J, Henriet S, Kilic SS, Karali Y, Gonzalez-Granado LI, Sediva A. Challenges in investigating patients with isolated decreased serum IgM - The SIMcal study. Scand J Immunol. 2019. Jun;89(6):e12763.
252- Tafakori Delbari M, Cheraghi T, Yazdani R, Fekrvand S, Delavari S, Azizi G, Chavoshzadeh Z, Mahdaviani SA, Ahanchian H, Khoshkhui M, Behmanesh F, Aleyasin S, Esmaeilzadeh H, Jabbari-Azad F, Fallahpour M, Zamani M, Madani SP, Moazzami B, Habibi S, Rezaei A, Lotfalikhani A, Movahed M, Shariat M, Kalantari A, Babaei D, Darabi M, Parvaneh N, Rezaei N, Abolhassani H, Aghamohammadi A. Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-IgM Syndrome in Iran. Int Arch Allergy Immunol. 2019;180(1):52-63.
253- Habibi S, Zaki-Dizaji M, Rafiemanesh H, Lo B, Jamee M, Gámez-Díaz L, Salami F, Kamali AN, Mohammadi H, Abolhassani H, Yazdani R, Aghamohammadi A, Anaya JM, Azizi G. Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review. J Allergy Clin Immunol Pract. 2019. Sep - Oct;7(7):2379-2386.
254- Yazdani R, Moazzami B, Madani SP, Behniafard N, Azizi G, Aflatoonian M, Abolhassani H, Aghamohammadi A. Candidiasis associated with very early onset inflammatory bowel disease: First IL10RB deficient case from the National Iranian Registry and review of the literature. Clin Immunol. 2019. Aug;205:35-42.
255- Bagheri Y, Vosughi A, Azizi G, Yazdani R, Kiaee F, Hafezi N, Alimorad S, Khoshmirsafa M, Seif F, Hassanpour G, Abolhassani H, Aghamohammadi A. Comparison of Clinical and Immunological Features and Mortality in Common Variable Immunodeficiency and Agammaglobulinemia Patients. Immunology Letters. 2019. Jun;210:55-62.
256- Maródi L, Abolhassani H, Aghamohammadi A, Avcin T, Bataneant M, Belevtsev M, Bernatowska E, Bolkov M, Bondarenko A, Caliskaner Z, Chernyshova L, Ciznar P, El-Marsafy A, Erdős M, Galal N, Guseva M, Iritsyan S, Ismaili-Jaha V, Kelecic J, Kondratenko I, Kostyuchenko L, Kovzel E, Kuli-Lito G, Lázár I, Litzman J, Mironska K, Mulaosmanovich V, Naumova E, Nashrullayeva G, Pac M, Pagava K, Pasic S, Pischalnikov A, Prokofjeva T, Reisli I, Resaei N, Ress K, Savchak I, Sciuca S, Sediva A, Serban M, Sharapova S, Sitkauskiene B, Skomska M, Szolnoky M, Tóth B, Totolian A, Tuzankina I, Vamos K, Volokha A. Fifteen Years of the J Project. J Clin Immunol. 2019. May;39(4):363-369.
257- Moazzami B, Yazdani R, Azizi G, Kiaei F, Tafakori M, Modaresi M, Shirzadi R, Mahdaviani SA, Sohani M, Abolhassani H, Aghamohammadi A. Respiratory Complications in Patients with Hyper IgM Syndrome. J Clin Immunol. 2019. Aug;39(6):557-568.
258- Shaghaghi M, Shahmahmoodi S, Nili A, Abolhassani H, Madani SP, Nejati A, Yousefi M, Kandelousi YM, Irannejad M, Shaghaghi S, Zahraei SM, Mahmoudi S, Gouya MM, Yazdani R, Azizi G, Parvaneh N, Aghamohammadi A. Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran. Emerg Infect Dis. 2019 Nov;25(11):2005-2012.
259- Shahbazi Z, Parvaneh N, Shahbazi S, Rahimi H, Hamid M, Shahbazi D, Delavari S, Abolhassani H, Aghamohammadi A, Mahdian R. Graft versus host disease and microchimerism in a JAK3 deicient patient. Allergy Asthma Clin Immunol. 2019. Aug 22;15:47.
260- Kiaee F, Azizi G, Rafiemanesh H, Zainaldain H, Sadaat Rizvi F, Alizadeh M, Jamee M, Mohammadi S, Habibi S, Sharifi L, Jadidi-Niaragh F, Yazdani R, Abolhassani H, Aghamohammadi A. Malignancy in Common Variable Immunodeficiency: A Systematic Review and Meta-Analysis. Expert Rev Clin Immunol. 2019 Oct;15(10):1105-1113.
261- Shahbazi Z, Yazdani R, Shahkarami S, Shahbazi S, Hamid M, Sadeghi-Shabestari M, Momen T, Aleyasin S, Esmaeilzadeh H, Darougar S, Delavari S, Mahdaviani SA, Ahanchian H, Behmanesh F, Kiaee F, Shariat M, Keramatipour M, Rezaei N, Abolhassani H, Parvaneh N, Mahdian R, Aghamohammadi A. Genetic Mutations and Immunological Features of Severe Combined Immunodeficiency Patients in Iran. Immunol Lett. 2019 Oct 4;216:70-78.
262- Ghorbani M, Fekrvand S, Shahkarami S, Yazdani R, Sohani M, Shaghaghi M, Hassanpour G, Mohammadi J, Negahdari B, Abolhassani H, Aghamohammadi A. The evaluation of neutropenia in common variable immune deficiency patients. Expert Review of Clinical Immunology. 2019. Nov;15(11):1225-1233.
263- Bagheri Y, Babaha F, Falak R, Yazdani R, Azizi G, Sadri M, Abolhassani H, Shekarabi M, Aghamohammadi A. IL-10 Induces TGF-b Secretion and TGF-b Receptor II Upregulation and IgA secretion in B cells. European Cytokine Network. 2019 Sep 1;30(3):107-113.
264- Boisson-Dupuis S, Ramirez-Alejo, Z. Li, E. Patin, G. Rao, G. Kerner, C. K. Lim, D. N. Krementsov, N. Hernandez, C. S. Ma, Q. Zhang, J. Markle, R. Martinez-Barricarte, K. Payne, R. Fisch, C. Deswarte, J. Halpern, M. Bouaziz, J. Mulwa, D. Sivanesan, T. Lazarov, R. Naves, P. Garcia, Y. Itan, B. Boisson, A. Checchi, F. Jabot-Hanin, A. Cobat, A. Guennoun, C. C. Jackson, S. Pekcan, Z. Caliskaner, J. Inostroza, B. T. Costa-Carvalho, J. A. T. Albuquerque, H. Garcia-Ortiz, L. Orozco, T. Ozcelik, A. Abid, I. A. Rhorfi, H. Souhi, H. N. Amrani, A. Zegmout, F. Geissmann, S. W. Michnick, I. Muller-Fleckenstein, B. Fleckenstein, A. Puel, M. J. Ciancanelli, N. Marr, Abolhassani H, M. E. Balcells, A. Condino-Neto, A. Strickler, K. Abarca, C. Teuscher, H. D. Ochs, I. Reisli, E. H. Sayar, J. El-Baghdadi, J. Bustamante, L. Hammarström, S. G. Tangye, S. Pellegrini, L. Quintana-Murci, L. Abel, J.-L. Casanova. Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Science Immunology. 2018 Dec 21;3(30).
265- Abolhassani H, Chou J, Bainter W, Platt C, Tavassoli M, Momen T, Tavakol M, Eslamian MH, Gharagozlou M, Movahedi M, Ghadami M, Hamidieh AA, Azizi G, Yazdani R, Afarideh M, Ghajar A, Havaei A, Chavoushzadeh Z, Mahdaviani SA, Cheraghi T, Behniafard N, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Mansouri M, Mesdaghi M, Babaie D, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari N, Ahanchian H, Khoshkhui M, Soheili H, Dabbaghzadeh A, Shirkani A, Nasiri Kalmarzi R, Mortazavi SH, Tafaroji J, Khalili A, Mohammadi J, Negahdari B, Joghataei MT, al-Ramadi BK, Picard C, Parvaneh N, Rezaei N, Chatila T, Massaad MJ, Keles S, Hammarström L, Geha RS, Aghamohammadi A. Clinical, Immunological and Genetic Spectrum of 696 Patients with Combined Immunodeficiency. J Allergy Clin Immunol. 2018. Apr;141(4):1450-1458.
266- Pan-Hammarström Q, Abolhassani H, Hammarström L. Defects in plasma cell differentiation is associated with primary immunodeficiency in humans. J Allergy Clin Immunol. 2018. Apr;141(4):1217-1219.
267- Gardulf A, Abolhassani H, Gustafson R, Eriksson L, Hammarström L. Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency (CVID). J Allergy Clin Immunol. 2018;142:1922-31.
268- Azizi G, Yazdani R, Rae W, Abolhassani H, Rojas M, Aghamohammadi A, Anaya JM. Monogenic polyautoimmunity in primary immunodeficiency diseases. Autoimmun Rev. 2018. Oct;17(10):1028-1039.
269- Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Habibi S, Gharagozlou M, Movahedi M, Hamidieh AA, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari A, Mansouri M, Mesdaghi M, Babaie D, Ahanchian H, Khoshkhui M, Soheili H, Eslamian MH, Cheraghi T, Dabbaghzadeh S, Tavassoli M, Kalmarzi RN, Mortazavi SH, Kashef S, Esmaeilzadeh H, Tafaroji J, Khalili A, Zandieh F, Sadeghi-Shabestari M, Darougar S, Behmanesh F, Akbari H, Zandkarimi M, Abolnezhadian F, Fayezi A, Moghtaderi M, Ahmadiafshar A, Shakerian B, Sajedi V, Taghvaei B, Safari M, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Bazregari S, Bazargan N, Fallahpour M, Khayatzadeh A, Javahertrash N, Bashardoust B, Zamani M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahim M, Ashournia P, Razaghian A, Rezaei A, Mamishi S, Parvaneh N, Rezaei N, Hammarström L, Aghamohammadi A. Fourth Update on Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis. J Clin Immunol. 2018. Oct; 38:816–832
270- Xia Y, He T, Luo Y, Li C, Lim CK, Abolhassani H, Yang J, Hammarström L. Targeted next-generation sequencing for genetic diagnosis of 160 patients with primary immunodeficiency in South China. Pediatr Allergy Immunol. 2018 Dec;29(8):863-872.
271- Azizi G, Jamee M, Yazdani R, Bagheri Y, Fayaz F, Jadidi-Niaragh F, Abolhassani H, Aghamohammadi A. CTLA-4 expression in CD4+ T cells from patients with LRBA deficiency and common variable immunodeficiency with no known monogenic disease. J Investig Allergol Clin Immunol. 2018.28(6). 422-424.
272- Azizi G, Mirshafiey A, Abolhassani H, Yazdani R, Ghanavatinejad A, Noorbakhsh F, Rezaei N, Aghamohammadi A. The imbalance of circulating T helper subsets and regulatory T cells in patients with LRBA deficiency: correlation with disease severity. J Cell Physiol. 2018. Nov;233(11):8767-8777.
273- Abolhassani H, Rezaei N, Aghamohammadi A. Recent Advances and Current Status of Primary Immunodeficiency Disease in Iran. Immunology and Genetics Journal. 2018. Oct; 1 (1):1-33.
274- Shaghaghi M, Irannejad M, Abolhassani H, Shahmahmoodi S, Hamidieh AA, Soleyman-Jahi S, Yazdani R, Azizi G, Aghamohammadi A. Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation; A Case Report and Review of Literature. J Clin Immunol. 2018. Jul;38(5):610-616.
275- Azizi G, Bagheri Y, Tavakol M, Askarimoghaddam F, Poorrostami K, Rafiemanesh H, Yazdani R, Kiaee F, Habibi S, Abouhamzeh K, Mohammadi H, Qorbani M, Abolhassani H, Aghamohammadi A. The clinical and immunological features of patients with primary antibody deficiencies. Endocr Metab Immune Disord Drug Targets. 2018. 2018;18(5):537-545.
276- Shaghaghi ¬¬¬¬M, Soleyman-jahi S, Abolhassani H, Yazdani R, Azizi G, Rezaei N, Barbouche MR, McKinlay MA, Aghamohammadi A. New Insights into Physiopathology of Immunodeficiency-Associated Vaccine-Derived Poliovirus Infection; Systematic Review of over 5 Decades of Data. Vaccine. 2018. Mar 20;36(13):1711-1719.
277- Maccari M, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, Baris S, Barzaghi F, Baxendale H, Buckland M, Burns S, Cancrini C, Cant A, Cathébras P, Cavazzana, Chandra M, Conti F, Coulter T, Devlin L, Edgar J, Faust S, Fischer A, Prat M, Hammarström L, Heeg M, Jolles S, Karakoc-Aydiner E, Kindle G, Kiykim A, Kumararatne D, Grimbacher B, Longhurst H, Mahlaoui N, Milota T, Moreira F, Moshous D, Mukhina A, Neth O, Neven B, Nieters A, Olbrich P, Ozen A, Schmid J, Picard C, Prader S, Rae W, Reichenbach J, Rusch S, Savic S, Scarselli A, Scheible R, Sediva A, Sharapova S, Shcherbina A, Slatter M, Soler-Palacin P, Stanislas A, Suarez F, Tucci F, Uhlmann A, van Montfrans J, Warnatz K, Williams A, Wood P, Kracker S, Condliffe A, Ehl S. Disease evolution and response to rapamycin in Activated PI3Kδ Syndrome: the ESID-APDS registry. Front Immunol. 2018. Mar 16;9:543.
278- Yousefzadegan S, Tavakol M, Abolhassani H, Nadjafi A, Mansouri S, Yazdani R, Azizi G, Negahdari B, Rezaei N, Aghamohammadi A. Systematic Investigation for Underlying Causes of Recurrent Infections in Children: Surveillance of Primary Immunodeficiency. Eur Ann Allergy Clin Immunol. 2018. Mar;50(2):72-80.
279- Azizi G, Mirshafiey A, Abolhassani H, Yazdani R, Ansariha FJ, Shaghaghi M, Mortazavi-Jahromi SS, Noorbakhsh F, Rezaei N, Aghamohammadi A. Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodeficiency Without Known Monogenic Disease. J Investig Allergol Clin Immunol. 2018;28(3):172-181
280- Azizi G, Kiaee F, Hedayat H, Yazdani R, Dolatshahi E, Alinia T, Mohammadikhajehdehi S, Mohammadi H, Ziaee V, Abolhassani H, Aghamohammadi A. Rheumatologic Complications in a Cohort of 227 Patients with Common variable immunodeficiency. Scand J Immunol. 2018. May;87(5):e12663.
281- Zaki‑Dizaji M, Akrami SM, Azizi G, Abolhassani H, Aghamohammadi A. Inflammation, a significant player of Ataxia–Telangiectasia pathogenesis. Inflamm Res. 2018. Jul;67(7):559-570.
282- Mahmoodi M, Abolhassani H, Mozdarani H, Safari Z, Ramyar A, Mohagheghi MA, Farzanfar F, Divsalar K, Nasiri Kalmarzi R, Mirminachi B, Aghamohammadi A. In vitro Chromosomal Radiosensitivity in Patients with Common Variable Immunodeficiency. Cent Eur J Immunol. 2018;43(2):155-161.
283- Azizi G, Kiaee F, Tavakolinia N, Rafiemanesh H, Mohammadikhajehdehi S, Sharifi L, Yazdani R, Abolhassani H, Aghamohammadi A. Mannose-binding lectin protein deficiency among patients with primary immunodeficiency disease receiving IVIG therapy. Endocr Metab Immune Disord Drug Targets. 2018. Feb 13;18(2):175-183.
284- Azizi G, Abolhassani H, Kiaee F, Tavakolinia N, Rafiemanesh H, Yazdani R, Mahdaviani SA, Mohammadikhajehdehi S, Tavakol M, Ziaee V, Negahdari B, Mohammadi J, Mirshafiey A, Aghamohammadi A. Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency. Allergol Immunopathol. 2018. Mar - Apr;46(2):127-135.
285- Azizi G, Abolhassani H, Yazdani R, Aghamohammadi A. Polyautoimmunity in Patients with LPS-Responsive Beige-like Anchor (LRBA) Deficiency. Immunol Invest. 2018. Jul;47(5):457-467.
286- Azizi G, Abolhassani H, Yazdani R, Mohammadikhajehdehi S, Parvaneh N, Negahdari B, Mohammadi J, Aghamohammadi A. Two different faces of LRBA deficiency in siblings: hypogammaglobulinemia versus normal immunoglobulin levels. J Investig Allergol Clin Immunol. 2018;28(1):48-50.
287- Abolhassani H, Edwards E, Ikinciogullari K, Jing H, Borte S, Buggert M, Du L, Matsuda-Lennikov M, Romano R, Caridha R, Bade S, Zhang Y, Frederiksen J, Fang M, Bal S, Haskologlu S, Dogu F, Tacyildiz N, Matthews H, McElwee J, Gostick E, Price D, Palendira U, Aghamohammadi A, Boisson B, Rezaei N, Karlsson A, Lenardo M, Casanova J, Hammarström L, Tangye S, Su H, Pan-Hammarström Q. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med. 2017 Jan;214(1):91-106.
288- Yazdani R, Abolhassani H#, Tafaroji J, Azizi G, Geha RS, Aghamohammadi A. Cernunnos Deficiency Associated with BCG Adenitis and Autoimmunity: First Case from the National Iranian Registry and Review of the Literature. Clin Immunol. 2017. Jul 17;183:201-206.
289- Yazdani R, Abolhassani H, Asgardoon M, Shaghaghi M, Modaresi M, Azizi G, Aghamohammadi A. Infectious and Non-Infectious Pulmonary Complications in Primary Immunodeficiencies. J Investig Allergol Clin Immunol 2017;27(4):213-224.
290- Tak Manesh A, Azizi G, Heydari A, KiaeeF, Shaghaghi M, Nazer NH, Yazdani R, Abolhassani H, Aghamohammadi A. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol. 2017. Nov - Dec;45(6):602-615.
291- Mohebbi A, Azizi G, Tavakolinia N, Karimipour M, Kiaee F, Yazdani R, Sadat Ebrahimi S, Ebrahimi M, Rafiemanesh H, Tafaroji J, Ziaee V, Abolhassani H, Aghamohammadi A. Comparison of Bone Mineral Density in Common variable immunodeficiency and X-Linked Agammaglobulinaemia Patients. Endocr Metab Immune Disord Drug Targets. 2017;17(2):134-140.
292- Zaki M, Akrami SM, Abolhassani H, Rezaei N, Aghamohammadi A. Ataxia Telangiectasia Syndrome: moonlighting ATM. Expert Rev Clin Immunol. 2017 Dec;13(12):1155-1172.
293- Azizi G, Abolhassani H, Mahdaviani SA, Chavoshzadeh Z, Eshghi P, Yazdani R, Kiaee F, Shaghaghi M, Mohammadi J, Rezaei N, Hammarström L, Aghamohammadi A. Clinical, Immunological, Molecular Analyses and Outcomes of Iranian Patients with LRBA Deficiency: A Longitudinal Study. Pediatr Allergy Immunol. 2017. Aug;28(5):478-484.
294- Aghamohammadi A, Abolhassani H#, Kutukculer N, Wassilak SG, Pallansch MA, Kluglein S, Quinn J, Sutter RW, Wang X, Sanal O, Latysheva T, Ikinciogullari A, Bernatowska E, Tuzankina IA, Costa-carvalho BT, Franco JL, Somech R, Karakoc-Aydiner E, Singh S, Bezrodnik L, Espinosa-Rosales FJ, Shcherbina A, Lau YL, Nonoyama S, Modell F, Modell V, Barbouche M, Mckinlay M. Patients with Primary Immunodeficiencies are a Reservoir of Poliovirus and a Risk to Polio Eradication. Front Immunol. 2017. Jun 13;8:685.
295- Valizadeh A, Yazdani R, Azizi G, Abolhassani H, Aghamohammadia A. Comparison of Clinical and Immunologic Phenotypes in Familial and Sporadic Forms of Common Variable Immunodeficiency. Scand J Immunol. 2017. Oct;86(4):239-247.
296- Azizi G, Abolhassani H, Yazdani R, Mohammadikhajehdehi S, Parvaneh N, Negahdari B, Mohammadi J, Aghamohammadi A. New Therapeutic Approach by Sirolimus for Enteropathy Treatment in Patients with LRBA Deficiency. 2017. Eur Ann Allergy Clin Immunol. 2017 Sep;49(5):235-239.
297- Bazregari S, Azizi G, Tavakol M, Asgardoon MH, Kiaee F, TavakoliniaN, Valizadeh A, Abolhassani H, Aghamohammadi A. Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency. Cent Eur J Immunol. 2017;42(4):336-341.
298- Azizi G, Tavakol M, Rafiemanesh H, Kiaee F, Yazdani R, Heydari A, Abouhamzeh K, Anvari P, Mohammadikhajehdehi S, Sharifi L, Bagheri Y, Mohammadi H, Abolhassani H, Aghamohammadi A. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017. Nov;13(11):1099-1106.
299- Ganjalikhani-Hakemi M, Yazdani R, Esmaeili M, Abolhassani H, Rae W, Azizi G, Dizaji MZ, Shaghaghi M, Abbasi-Rad F, Rezaei A, Afshar-Qasemloo S, Mohammadi S, Rezaei N, Aghamohammadi A. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (CVID). Endocr Metab Immune Disord Drug Targets. 2017 Nov 16;17(4):332-340.
300- Gholami K, Laali E, Abolhassani H, Ahmadvand A, Mohebbi N, Javadi MR, Aghamohammadi A, Rezaei N. Costs of hospital admission on primary immunodeficiency diseases. Iran J Public Health. 2017 Mar 46 (3), 342-350.
301- Aghamohammadi A, Abolhassani H, Puchalka J, Greif-Kohistani N, Klein C, Rezaei N. Preference of Genetic Diagnosis of CXCR4 Mutation Compared with Clinical Diagnosis of WHIM Syndrome. J Clin Immunol. 2017 Apr;37(3):282-286.
302- Yazdani R, Azizi G, Abolhassani H, Aghamohammadi A. Selective IgA deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Scand J Immunol. 2017 Jan;85(1):3-12.
303- Shirkani A, Shahrooei M, Azizi G, Rokni-Zadeh H, Abolhassani H, Farrokhi S, Frans G, Bossuyt X, Aghamohammadi A. Novel Mutation of ZAP70-related Combined Immunodeficiency: First Case from the National Iranian Registry and Review of the Literature. Immunol Invest. 2017 Jan;46(1):70-79.
304- Ghiasy S, Parvaneh L, Azizi G, Sadri G, Zaki dizaji M, Abolhassani H, Aghamohammadi A. The Clinical Significance of Complete Class Switching Defect in Ataxia Telangiectasia Patients. Expert Rev Clin Immunol. 2017 May;13(5):499-505.
305- Azizi G, Abolhassani H, Yazdani R, Rezaei N, Mirshafiey A, Aghamohammadi A. Approach to the management of autoimmunity in primary immunodeficiency. Scand J Immunol. 2017 Jan;85(1):13-29.
306- Yazdani R, Ganjalikhani-Hakemi M, Esmaeili M, Abolhassani H, Vaeli S, Rezaei A, Sharifi Z, Azizi G, Rezaei N, Aghamohammadi A. Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency. Clin Immunol. 2017 Feb;175:124-132.
307- Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Rezaei N, Ochs HD, Aghamohammadi A. Autoimmunity in Common Variable Immunodeficiency: Epidemiology, Pathophysiology and Management. Expert Rev Clin Immunol. 2017 Feb;13(2):101-115.
308- Ataeinia B, Tavakol M, Abolhassani H, Kiaei F, Aghamohammadi A. Measurement of Health-Related Quality of Life in Primary Antibody Deficient Patients. Immunol Invest. 2017 May;46(4):329-340.
309- Yazdani R, Seify R, Ganjalikhani-Hakemia M, Abolhassani H, Eskandari N, Golsaz-Shirazi F, Ansaripour B, Salehi E, Azizi G, Rezaei N, Aghamohammadi A. Comparison of Various Classifications for Patients with Common Variable Immunodeficiency (CVID) using Measurement of B-cell Subsets. J Investig Allergol Clin Immunol. 2017 Mar - Apr;45(2):183-192.
310- Morena M, Leonard D, Torgerson T, Cabral-Marques O, Mary M, Aghamohammadi A, Chandra S, Murguia-Favela L, Bonilla F, Kanariou M, Damrongwatanasuk R, Kuo C, Dvorak C, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Espanol T, Shcherbina A, Hanson C, Litzman J, Routes J, Wong M, Fuleihan R, Seneviratne S, MD, Small T, Janda A, Bezrodnik L, Seger R, Gomez Raccio A, Edgar J, Chou J, Abbott J, van Montfrans J, Gonzalez-Granado L, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, et al. Long term outcomes of 176 patients with X-linked hyper IgM syndrome. J Allergy Clin Immunol. 2017 Apr;139(4):1282-1292.
311- Azizi G, Ahmadi M, Abolhassani H, Yazdani R, Mohammadi H, Mirshafiey A, Rezaei N, Aghamohammadi A. Autoimmunity in Primary Antibody Deficiencies. Int Arch Allergy Immunol. 2016 Dec 24;171(3-4):180-193.
312- Azizi G, Abolhassani H, Aghamohammadi A. Cellular and Molecular Mechanisms of Immune Dysregulation and Autoimmunity associated with Primary Immunodeficiencies. Cell Immunol. 2016 Dec;310:14-26.
313- Azizi G, Abolhassani H, Rezaei N, Aghamohammadi A, Asgardoon MH, Rahnavard J, Dizaji MZ, Yazdani R. The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases.
Endocr Metab Immune Disord Drug Targets. 2016;16(2):80-88.
314- Abolhassani H, Aghamohammadi A, Hammarstrom L. Monogenic Mutations Associated with IgA Deficiency. Expert Rev Clin Immunol. 2016 Dec;12(12):1321-1335.
315- Shaghaghi M, Shahmahmoodi S, Abolhassani H, Soleyman-jahi S, Parvaneh N, Mahmoudi S, Chavoshzadeh Z, Yazdani R, Zahraei SM, Ebrahimi M, Eslamian MH, Tabatabaie H, Yousefi M, Mollaie Kandelousi Y, Oujaghlou A, Rezaei N, Aghamohammadi A. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995-2014. Emerging Infectious Diseases. 2016. Oct;22(10):1712-9.
316- Nejatbakhsh F, Shirbeigi L, Rahimi R, Abolhassani H*. Review of the Local Herbal Compounds Found in the Iranian Traditional Medicine Known to Optimize Male Fertility. Andrologia. 2016. Oct;48(8):850-9.
317- Marefat H, Ghareje Daghi M, Abolhassani H, Azizi G, Aghamohammadi A. Early Onset Steroid Induced Posterior Subcapsular Cataract in a Patient with Common Variable Immunodeficiency: Case Reports and Review of Literature. European Annals of Allergy and Cell Immunol. 2016. Sep;48(5):197-201.
318- Azizi G, Ghanavatinejad A, Abolhassani H, Yazdani R, Rezaei N, Mirshafiey A, Aghamohammadi A. Autoimmunity in primary T-cell immunodeficiencies. Expert Rev Clin Immunol. 2016. Sep;12(9):989-1006.
319- Mokhtaria M, Shakeri A, Mirminachi B, Abolhassani H, Yazdania R, Grimbacherd B, Aghamohammadi A. Important Factors Influencing Severity of Common Variable Immunodeficiency. Archives of Iranian Medicine. 2016. Aug;19(8):544-50.
320- Yazdani R, Heydari A, Azizi G, Abolhassani H, Aghamohammadi A. Asthma and Allergic Diseases in a Selected Group of Patients With Common Variable Immunodeficiency. J Investig Allergol Clin Immunol. 2016;26(3):209-11.
321- Fang M, Abolhassani H, Lim CK, Zhang J, Hammarström L. Next Generation Sequencing Data Analysis in Primary Immunodeficiency Disorders - Future Directions. J Clin Immunol. 2016. May;36 Suppl 1:68-75.
322- Raeisi M, Azizi G, Abolhassani H, Aghamohammadi A. Lymphocytic interstitial pneumonitis: An unusual presentation of X-linked hyper Ig M syndrome. Iranian Journal of Pediatrics. 2016. Mar 5;26(2):e3656.
323- Yazdani R, Abolhassani H, Rezaei N, Azizi G, Hammarström L, Aghamohammadi A. Evaluation of Known Defective Signaling-Associated Molecules in Patients Who Primarily Diagnosed as Common Variable Immunodeficiency. International Reviews of Immunology. 2016. Jan 2;35(1):7-24.
324- Abolhassani H, Vitali M, Lougaris V, Giliani S, Parvaneh N, Parvaneh L, Mirminachi B, Cheraghi T, Khazaei H, Mahdaviani A, Kiaei F, Mohammadi J, Negahdari B, Hammarstrom L, Plebani A, Aghamohammadi A. Cohort of Iranian Patients with Congenital Agammaglobulinemia: Mutation Analysis and Novel Gene Defects. Expert Rev Clin Immunol. 2016. Apr;12(4):479-86.
325- Yazdani R; Fatholahi M; Ganjalikhani-Hakemi M; Abolhassani H; Azizi G; Magaji K; Rezaei N; Aghamohammadi A. Role of Apoptosis in Common Variable Immunodeficiency and Selective Immunoglobulin A deficiency. Molecular Immunology. 2016. Mar;71:1-9.
326- Alkhairy OK, Abolhassani H, Rezaei N, Fang M, Krogh Andersen K, Chavoshzadeh Z, Mohammadzadeh I, El-Rajab MA, Massaad M, Chou C, Aghamohammadi A, Geha RS, Hammarstrom L. Spectrum of Phenotypes Associated with Mutations in LRBA. J Clin Immunol. 2016 Jan;36(1):33-45.
327- Rajebi H, Khodadad A, Fahimi G, Abolhassani H. Vitamin D Deficiency Among Female Nurses of Children’s Medical Center Hospital and Its Related Factors. Acta Medica Iranica. 2016. Feb;54(2):146-50.
328- Azizi G, Abolhassani H, Asgardoon MH, Shaqaqi MR, Aghamohammadi A. Managing Patients with Side Effects and Adverse Reactions to Immunoglobulin Therapy. Expert Rev Clin Pharmacol. 2016 Jan;9(1):91-102
329- Mohammadinejad P, Pourhamdi S, Abolhassani H, et al. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30 Years Experiment. Journal of Investigational Allergology and Clinical Immunology. J Investig Allergol Clin Immunol. 2015. Dec. 25(6): 416-425.
330- Shahinpour S, Tavakol M, Abolhassani H, Mirminachi B, Mohammadinejad P, Aghamohammadi A. Report on the First Survey of Iranian Patients with Hereditary Angioedema. Iran J Immunol. 2015 Sep; 12(3)129-133.
331- Abolhassani H, Asgardoon MH, Rezaei N, Hammarstrom L, Aghamohammadi A. Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient? Expert Rev Clin Immunol. 2015 Nov;11(11):1229-43.
332- Alkhairy O, Perez-Becker R, Driessen G, Abolhassani H, et al. Novel Mutations in TNFRSF7: Clinical, Immunological and Genetic Characterization of Human CD27 Deficiency. J Allergy Clin Immunol. 2015. Sep;136(3):703-712.
333- Yazdani R, Latif A, Tabassomi F, Abolhassani H, Azizi G, Rezaei N, Aghamohammadi A. Clinical phenotype classification for selective immunoglobulin A deficiency. Expert Rev Clin Immunol. 2015 Nov;11(11):1245-54.
334- Sadeghi B, Abolhassani H*, Naseri A, Rezaei N, Aghamohammadi A. Economic burden of common variable immunodeficiency: annual cost of disease. Expert Rev Clin Immunol. 2015 May;11(5):681-8.
335- Alkhairy O, Rezaei, N, Graham R, Abolhassani H, Stephan B, Hultenby K, Wu C, Aghamohammadi A, Williams D, Behrens T, Hammarström L, Pan-Hammarström Q.A Novel RAC2 Mutation in Two Siblings Associated with Features of Common Variable Immunodeficiency. J Allergy Clin Immunol. 2015 May;135(5):1380-4.
336- Abolhassani H, Cheraghi T, Rezaei N, Aghamohammadi A, Hammarström L. Common Variable Immunodeficiency or Late Onset Combined Immunodeficiency: New Hypomorphic JAK3 Patient and a Literature Review. J Investig Allergol Clin Immunol. 2015;25(3):218-20.
337- Abolhassani H, Gharib B, Shahinpour S, Masoom SN, Havaei A, Mirminachi B, Arandi N, Torabi-Sagvand B, Khazaei HA, Rezaei N, AghamohammadiA. Autoimmunity in Patients with Selective IgA Deficiency. J Investig Allergol Clin Immunol.2015;25(2):112-9.
338- TorabiSagvand B, Mirminachi B, Abolhassani H, Shokouhfar T, Keihanian T, Amirzargar A, Madaviani A, Aghamohammadi A. IgG Anti-IgA Antibodies in Pediatric Antibody Deficient Patients Receiving Intravenous Immunoglobulin. Allergologia et immunopathologia. 2015 Jul-Aug;43(4):403-8.
339- Abolhassani H, Rezaei N, Mohammadinejad P, Mirminachi B, Hammarström L, Aghamohammadi A. Important Differences in the Diagnostic Spectrum of Primary Immunodeficiency in Adults versus Children. Expert Rev Clin Immunol. 2015. Feb:11(2):289-302.
340- Mohammadinejad P, Abolhassani H, Pourhamdi S, Ghosh S, Sadeghi B, NasiriKalmarzi R, Durandy A, Borkhardt A, Aghamohammadi A. Class Switch Recombination Process in Ataxia Telangiectasia Patients with Elevated Serum Levels of IgM. Journal of Immunoassay and Immunochemistry. 2015;36(1):16-26.
341- Abolhassani H, Hirbod-Mobarakeh A, Shahinpour S, Panahi M, Mohammadinejad P, Mirminachi B, Shakari M; Samavat B; Aghamohammadi A. Mortality and Morbidity in Patients with X-linked Agammaglobulinemia. Allergol Immunopathol. 2015; Jan-Feb;43(1):62-6.
342- Abolhassani H, Wang N, Aghamohammadi A, Rezaei N, Lee YN, Frugoni F, Notrangelo LD, Pan-Hammarström Q, Hammarström L. A HypomorphicRAG1 Mutation Resulting in a Phenotype Resembling Common Variable Immunodeficiency. J Allergy Clin Immunol. 2014. Dec;134(6):1375-80.
343- Aghamohammadi A, Abolhassani H, AmirHosseinLatifet al. Long-Term Evaluation of a Historical Cohort of Iranian Common Variable Immunodeficiency Patients. Expert Rev ClinImmunol. 2014 Oct;10(10):1405-17.
344- Cheraghi T, Aghamohammadi A, Mirminachi B, Keihanian T, Hedayat E, Abolhassani H, Torabi Sagvand B, Rezaei N. Prediction of Common Variable Immunodeficiency Evolution: HLA Typing for Selective IgA Deficiency Patients. J Investig Allergol Clin Immunol. 2014;24(3):198-200.
345- Mohammadinejad P, Mirminachi B, Sadeghi B, Movahedi M, Gharagozlou M, Mohammadi J, Abolhassani H, Rezaei N, Aghamohammadi A. Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center, Tehran, Iran (2006-2013). Iran J Immunol. 2014 Dec;11(4):282-91.
346- Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al. Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry. J Clin Immunol. 2014 May;34(4):478-90.
347- Abolhassani H, Akbari F, Mirminachi B, Bazregari S, Hedayat E, Rezaei N, AghamohammadiA. Morbidity and Mortality of Iranian Patients with Hyper IgM Syndrome: a Clinical Analysis. Iran J Immunol. 2014.11(2):124-134.
348- Abolhassani H, Mirminachi B, Daryabeigi M, Agharahimi, Z, Aghamohammadi A, Ziaee V, Rabbani A, Rezaei N. Evaluation of Physicians’ Awareness of Pediatric Diseases in Iran. Iran J Pediatrics. 2014. 24(1):87-92.
349- Khalili A, Plebani A, Vitali M, Abolhassani H, Lougaris V, Mirminachi B, Rezaei N, Aghamohammadi. Autosomal Recessive Agammaglobulinemia: A Novel Non-sense Mutation in CD79α. J Clin Immunol. 2014 Feb;34(2):138-41.
350- Latif A, Tabassomi F, Abolhassani H*, Hammarström L. Molecular Diagnosis of Primary Immunodeficiency Diseases in a Developing Country: Iran as an Example. Expert Rev Clin Immunol. 2014 Mar;10(3):385-96.
351- Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, Aghamohammadi A. Combined Immunodeficiency Presenting with Vaccine-Associated Paralytic Poliomyelitis: A Case Report and Narrative Review of Literature. Immunol Invest. 2014;43(3):292-8.
352- Tavakol M, Kouhi A, Abolhassani H, Ghajar A, Afarideh M, Shahinpour S, Aghamohammadi A. Otologic Findings in Pediatric Patients with Hypogammaglobulinemia. Iran J Allergy Asthma Immunol. 2014 June; 13(3):166-173.
353- Abolhassani H, Parvaneh N, Rezaei N, Hammarström L, Aghamohammadi A. Genetic Defects of B cell Development and Their Clinical Consequences. J Investig Allergol Clin Immunol. 2014; 24 (1): 6-22.
354- Arandi N, Mirshafiey A, Jeddi-Tehrani M, Shaghaghi M, Sadeghi b, Abolhassani H, Sharifian R, Rahiminejad MS, Aghamohammadi A. Alteration in Frequency and Function of CD4+CD25+FOXP3+ Regulatory T cells in Patients with Immune Thrombocytopenic Purpura. Iran J Allergy Asthma Immunol.2014; 13(2):85-92.
355- Fallahi G, Aghamohammadi A, Khodadad A, Hashemi M, Mohammadinejad P, Asgarian-Omran H, Najafi M, Farhmand F, Motamed F, Soleimani K, Soheili H, Parvaneh N, Darabi B, NasiriKalmarzi R, Pourhamdi S, Abolhassani H, Mirminachi B, Rezaei N, Evaluation of Antibody Response to Polysaccharide Vaccine and Switched Memory B Cells in Pediatric Patients with Inflammatory Bowel Disease. Gut Liver. 2014 Jan;8(1):24-8.
356- Salehgargari S, Sahebdel B, Zare A, Abolhassani H. Ectopic Decidual Reaction Mimicking Irritable Bowel Syndrome: A Case Report. Acta Medica Iranica.2014. 52 (1), 88-90.
357- Ebadi M, Akhlaghi H, Zamani M, Beheshti H, Abolhassani H, Ayadi A, Dezdar J, Mortazzavi S, Karami G, IzadiM.The Correlation BetweenToxoplamaGondii Infection and Schizophrenia: A Comparative Study With Family Members (Control Group). Scimetr. 2014 January; 2(1): e15386.
358- Abolhassani H, Amirkashani D, Parvaneh N, Mohammadinejad P, Gharib B, Shahinpour S, Hirbod-Mobarakeh A, MirghorbaniM, Movahedi M, Gharagozlou M, Rezaei N, AghamohammadiA.Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2013 23(5) 323-9.
359- Abolhassani H, Farrokhi AS, Pourhamdi S, Mohammadinejad P, Sadeghi B, Moazzeni SM, Aghamohammadi A. Expression of Activation-Induced Cytidine Deaminase Gene in B Lymphocytes of Patients with Common Variable Immunodeficiency. Iran J Pediatrics. 2013 Aug 23(4) 451-7.
360- SalehiSadaghiani M, Aghamohammadi A, Hosseini F, Abolhassani H, Rezaei N. Autism in a Child with Common Variable Immunodeficiency. Iran J Allergy Asthma Immunol. 2013 Sep 12(3) 287-289.
361- Aghamohammadi A, Gholinejad Moghaddam Z, Abolhassani H, Hallaji Z, Mortazavi H, Pourhamdi S, Mohammadinejada P, Rezaeia N. Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis. Allergol Immuno pathol. 2013 May 15;12(2):176-81.
362- Rezaei N, Abolhassani H, Kasraian A, Mohammadinejad P, Sadeghi B, Aghamohammadi A. Family Study of Pediatric Patients with Primary Antibody Deficiencies. Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):377-82.
363- Abolhassani H, TorabiSgvand B, Shokuhfar T, Mirminachi B, Rezaei N, Aghamohammadi A, A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol. 2013 Jun;9(6):561-74.
364- Abolhassani H, Aghamohammadi A, Pourjabbar S, SalehiSadaghiani M, Nikayin S, Rabiee A, Imanzadeh A, Mahmoodi Gharaei J, Arbabi A, Rezaei N. Psychiatric Aspects of Primary Immunodeficiency Diseases: The Parental Study. Iran J Allergy Asthma Immunol June 2013; 12(2):176-181.
365- Farrokhi AS, Aghamohammadi A, Pourhamdi S, Mohammadinejad P, Abolhassani H, Moazzeni SM. Evaluation of class switch recombination in B lymphocytes of patients with common variable immunodeficiency. J Immunol Methods. 2013 Aug 30;394(1-2):94-9.
366- Izadi M, Abolhassani H, Fazel M, JonaidiJafari N. Influenza Vaccine: New Indication for Travelers. International Journal of Travel Medicine and Global Health, 2013 Spring 1(1):3-8.
367- Arandi N, Mirshafiey A, Jeddi-Tehrani M, Abolhassani H, Sadeghi B, Mirminachi B, Shaghaghi M, Aghamohammadi A. Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol. 2013 Feb;281(2):129-133.
368- Rahiminejad MS, Sadeghi M, Mohammadinejad P, Sadeghi B, Abolhassani H, DehghaniFiroozabadi MM, Fathi SM, Rezvani H, Bahoush G, Ehsani MA, Faranoush M, Mehrvar A, TorabiSagvand B, Ghadiani M, Rezaei N, AghamohammadiA. Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura. Iran J Allergy Asthma Immunol. 2013 Mar;12(1):50-6.
369- Arandi N, Mirshafiey A, Abolhassani H, Jeddi-Tehrani M, Edalat R, Sadeghi B, Shaghaghi M, Aghamohammadi A. Frequency and Expression of Inhibitory Markers of CD4+CD25+ FOXP3+ Regulatory T Cells in Patients with Common Variable Immunodeficiency. Scand J Immunol. 2013 May;77(5):405-12.
370- Izadi M, Zamani MM, Sabetkish N, Abolhassani H, Saadat SH, Taheri S, Dabirih.The Probable Role of Cytomegalovirus in Acute Myocardial Infarction. Jundishapur J Microb. 2014 May; 7(3):3-8.
371- Soheili H, Abolhassani H, Arandi N, Khazaei HA, Shahinpour S, Hirbod-Mobarakeh A, Rezaei N, Aghamohammadi A. Evaluation of Natural Regulatory T Cells in Subjects with Selective IgA Deficiency: From Senior Idea to Novel Opportunities. Int Arch Allergy Immunol. 2012 Sep 25;160(2):208-214.
372- Mahmoudi MJ, Mahmoudi M, Siassi F, Hedayat M, Pasalar P, Chamari M, Abolhassani H, Rezaei N, Saboor-Yaraghi, AA. Circulating retinol-binding protein 4 concentrations in patients with coronary artery disease and patients with type 2 diabetes mellitus. Int J Diabet Develop. 2012 Jun; 32(2):105-110.
373- Abolhassani H*, Naseri M, Mahmoudzadeh S. A survey of complementary and alternative medicine in Iran. Chin J Integr Med. 2012 Jun;18(6):409-16.
374- Aghamohammadi A, Abolhassani H, Mohammadinejad P, Rezaei N. The approach to children with recurrent infections. Iran J Allergy Asthma Immunol. 2012 Jun;11(2):89-109.
375- Abolhassani H, Sadaghiani MS, Aghamohammadi A, Ochs HD, Rezaei N. Home-Based Subcutaneous Immunoglobulin versus Hospital-Based Intravenous Immunoglobulin in Treatment of Primary Antibody Deficiencies: Systematic Review and Meta Analysis. J ClinImmunol. 2012 Dec;32(6):1180-92.
376- Mohammadinejad P, Aghamohammadi A, Abolhassani H, Sadaghiani MS, Abdollahzade S, Sadeghi B, Soheili H, Tavassoli M, Fathi SM, Tavakol M, Behniafard N, Darabi B, Pourhamdi S, Rezaei N. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Investig Allergol Clin Immunol. 2012;22(3):208-14.
377- Oraei M, Aghamohammadi A, Rezaei N, Bidad K, Gheflati Z, Amirkhani A, Abolhassani H, Massoud A. Naive CD4+ T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2012;22(3):160-7.
378- Abolhassani H, Aghamohammadi A, Imanzadeh A, Mohammadinejad LP, Sadeghi B, Rezaei N. Malignancy phenotype in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2012;22(2):133-4.
379- Mohammadzadeh I, Yeganeh M, Aghamohammadi A, Parvaneh N, Behniafard N, Abolhassani H, Tabassomi F, Hemmat M, Kanegane H, Miyawaki T, Ohara O, Rezaei N. Severe primary antibody deficiency due to a novel mutation of micro heavy chain. J Investig Allergol Clin Immunol. 2012;22(1):78-9.
380- Nourijelyani K, Aghamohammadi A, SalehiSadaghiani M, Behniafard N, Abolhassani H, Pourjabar S, Rezvanizadeh A, Khadamy J, Imanzaeh A, Sedaghat M, Rezaei N. Physicians awareness on primary immunodeficiency disorders in iran. Iran J Allergy Asthma Immunol. 2012 Mar;11(1):57-64.
381- Aghamohammadi A, Abolhassani H, Hirbod-Mobarakeh A, Ghassemi F, Shahinpour S, Behniafard N, Naghibzadeh G, Imanzadeh A, Rezaei N. The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis. Viral Immunol. 2012 Apr;25(2):161-5.
382- Behniafard N, Aghamohammadi A, Abolhassani H, Pourjabbar S, Sabouni F, Rezaei N. Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature.Expert Rev ClinImmunol. 2012 Feb;8(2):155-9.
383- Meighani G, Aghamohammadi A, Javanbakht H, Abolhassani H, Nikayin S, Jafari SM, GhandehariMotlagh M, Shamshiri AR, Rezaei N. Oral and dental health status in patients with primary antibody deficiencies. Iran J Allergy Asthma Immunol. 2011 Dec;10(4):289-93.
384- Abolhassani H, Ahamohammadi A, Abolhassani F, Eftekhar H, Heidarnia MA, Rezaei N. Health Policy for Common Variable Immunodeficiency: Burden of the Disease. J Investig AllergolClinImmunol 2011; Vol. 21(6) 454-458.
385- Rezaei N, Abolhassani H, Aghamohammadi A, Ochs H. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Rev ClinImmunol. 2011 May;7(3):301-16.
386- Aghamohammadi A, Abolhassani H, Biglari, Abolmaali S, Moazzami K, Tabatabaeiyan M, Asgarian-Omran H, Parvaneh N, Mirahmadian M, Rezaei N. Analysis of switched memory B cells in patients with IgA deficiency. Int Arch Allergy Immunol 2011: 156:462-468.
387- Aghamohammadi A, Bahrami A, Mamishi S, Mohammadi B, Abolhassani H, Parvaneh N, Rezaei N. Impact of delayed diagnosis in children with primary antibody deficiencies.J MicrobiolImmunol Infect. 2011 Jun;44(3):229-34.
388- Aghamohammadi A, Montazeri A, Abolhassani H, Saroukhani S, Pourjabbar S, Tavassoli M, Darabi B, Imanzadeh A, Parvaneh N, Rezaei N. Health-related quality of life in primary antibody deficiency.Iran J Allergy Asthma Immunol. 2011 Mar;10(1):47-51.
389- Ramyar A, Aghamohammadi A, Mozdarani H, Mahmoodi M, Azimi C, Safari Z, Nedaei HA, Farzanfar F, Rezaei N, Asadi-Shekaari M, Esfahani M, Hosseini SK, Yazdani M, Abolhassani H, Khalesi F, Mohagheghi MA. Assessment of in vitro chromosomal sensitivity to low doses of gamma irradiation in patients with acute lymphoblastic leukemia.BCCR.2011; 2: 2-6.
390- Mamishi S, Eghbali AN, Rezaei N, Abolhassani H, Parvaneh N, AghamohammadiA.A single center 14 years study of infectious complications leading to hospitalization of patients with primary antibody deficiencies .Braz J Infect Dis. 2010 Aug;14(4):351-5.
391- Aghamohammadi A, Imai K, Moazzami K, Abolhassani H, Tabatabaeiyan M, Parvaneh N, NasiriKalmarzi R, Nakagawa N, Oshima K, Ohara O, Nonoyama S, Rezaei N.Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.J Investig Allergol Clin Immunol. 2010;20(5):442-5.
392- Aghamohammadi A, Abolhassani H, Moazzami K, Parvaneh N, Rezaei N. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults.J Investig Allergol Clin Immunol. 2010;20(5):372-9.
393- Rostami K, Farzaneh E, Abolhassani H .Bilateral deep peroneal nerve paralysis following kerosene self-injection into external hemorrhoids.Case Report Med. 2010. pii: 850394. Epub 2010 Sep 29.
394- Aghamohammadi A, Shafiei A, Abolhassani H, Sherkat R, Mahjoub F, Rezaei N. Renal amyloidosis in common variable immunodeficiency .Nefrologia. 2010;30(4):474-6.
395- Aghamohammadi A, Abolhassani H, Rezaei N, Kalantari N, Tamizifar B, Cheraghi T, Parvaneh N, Yeganeh M, Moazzami K, Ebrahimi-Daryani N, Anaraki MR. Cutaneous granulomas in common variable immunodeficiency: case report and review of literature. Acta Dermatovenerol Croat. 2010 Jul;18(2):107-13.
396- Saroukhani S, Aghamohammadi A, Mahmoudi-GharaeiJ, Abolhassani H, Cheraghi T, Imanzaeh A, Moazzami K, Parvaneh N, Rezaei N.Behavior abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies.Hum Psychopharmacol. 2010 Jul;25(5):419-22.
397- Aghamohammadi A, Allahverdi A, Abolhassani H, Moazzami K, Alizadeh H, Gharagozlou M, Kalantari N, Sajedi V, Shafiei A, Parvaneh N, Mohammadpour M, Karimi N, Sadaghiani MS, Rezaei N.Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology. 2010 Feb;15(2):289-95.
398- Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, Imanzadeh A, Mohammadi J, Hammarström L. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009 Nov;29(6):769-76.
399- Aghamohammadi A, Tavassoli M, Abolhassani H, Parvaneh N, Moazzami K, Mahdaviani A, Atarod L; Rezaei N. Infectious and Non-Infectious Complications among Undiagnosed Patients with Common Variable Immunodeficiency. Iran J Pediatrics. 2009 Dec;19 (4):367-375.
400- Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, Parvaneh N, Abolhassani H, Pourpak Z, Moin M. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol. 2009 Jan;29(1):130-6.
401- Ramyar A, Aghamohammadi A, Moazzami K, Rezaei N, Yeganeh M, Cheraghi T, Pouladi N, Heydari G, Abolhassani H, Amirzargar AA, Parvaneh N, Moin M. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency .Iran J Allergy Asthma Immunol. 2008 Sep;7(3):169-75.
402- Tabatabaie P, Aghamohammadi A, Mamishi S, Isaeian A, Heidari G, Abdollahzade S, Pirouzi P, Rezaei N, Heidarnazhad H, Mirsaeid Ghazi B, Yeganeh M, CheraghiT, Abolhassani H, Saghafi S, Alizadeh H, Anaraki MR. Evaluation of humoral immune function in patients with bronchiectasis. Iran J Allergy Asthma Immunol. 2008 Jun;7(2):69-77.
No items yet!
No items yet!